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ABSTRACT 
Genome-wide Predictive Simulation on the Effect of Perturbation and the Cause of Phenotypic 
variations in Human Cells with Network Biology Approach  
In Sock Jang 
Thanks to modern high-throughput technologies such as microarray-based gene 
expression profiling, a large amount of molecular profile data have been generated in several 
disease related contexts. Despite the fact that these data likely contain systems-level information 
about disease regulation, revealing the underlying dynamics between genes and mechanisms of 
gene regulation in genome wide way remains a major challenge. Understanding these 
mechanisms in genome-wide fashion and the resulting dynamical behavior is a key goal of the 
nascent field of systems biology.  
One approach to dissect the logic of the cell, is to use reverse engineering algorithms 
that infer regulatory interactions form molecular profile data. In this context, use of information 
theoretic approaches has been very successful: for instance, the ARACNe algorithm has been 
able to successfully infer transcriptional interactions between transcription factors and their 
target genes; similarly, the MINDy algorithm has identified post-translational modulators of 
transcription factor activity by multivariate analysis of large gene expression profile datasets. 
Many methods have been proposed to improve ARACNe both from a computational efficiency 
perspective and in terms of increasing the accuracy of the predicted interactions. Yet, the main 
core of ARACNe, i.e., the data processing inequality (DPI), has remained virtually unaffected 
even though modern information theory has extended the DPI theorem into higher-order 
interactions. First, we introduce an improvement of ARACNe, hARACNe, which recursively 
applies a higher-order DPI analysis. We show that the new algorithm successfully detects false 
positive feed-forward loops involving more than three genes. Second, we extend the MINDy 
algorithm using co-information as a novel metric, thus replacing the conditional mutual 
information and significantly improving the algorithm’s predictions.  
Largely, two ultimate goals of systems perturbation studies are to reveal how human 
diseases are connected with the genes, and to find regulatory mechanism that determine disease 
cell behavior. However, these goals remain daunting: even the most talented researchers still 
have to rely on laborious genetic screens and very simplified hypotheses about effects of given 
perturbation have been experimentally validated and roughly analyzed with very limited 
regulatory sub-network such as pathway. To overcome these limitations, use of gene regulatory 
network is explored in this thesis research. Specifically, we propose creation of a new algorithm 
that can accurately predict cell state in genome-wide fashion following perturbation of individual 
genes, such as from silencing or ectopic expression experiments. Furthermore, experimentally 
validated methods to predict genome-wide changes in a cellular system following a genetic 
perturbation (e.g., gene silencing or ectopic expression) are still unavailable, and even though 
phenotypic variations are experimentally profiled and gene signatures are selected by being 
statistically tested, finding the exact regulator which systematically causes significant variations 
of gene signature is still quite challenging.   
In this research, I introduce and experimentally validate a probabilistic Bayesian method 
to simulate the propagation of genetic perturbations on integrated gene regulatory networks 
inferred by the hARACNe and coMINDy algorithms from human B cell data. With the same 
predictive framework, we also computationally predict the master driver (regulator) that is most 
likely to have produced the observed variations in gene expression levels; these studies as a 
systematized pre-screening process before genetic manipulation. I predict in silico the effect of 
silencing of several genes as well as the cause of phenotypic variations. Performance analysis, 
tested by Gene Set Enrichment Analysis (GSEA), shows that the new methods are highly 
predictive, thus providing an initial step toward building predictive probabilistic regulatory 
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The ultimate goal of systems biology is to reveal the inter-functional mechanisms 
between genes through a systematic understanding of gene dynamics and gene regulation 
involved in normal biology and disease. To this end, perturbation studies have been used to 
systematically examine the molecular mechanisms involved in diseases such as cancer. There 
have been two major goals of these perturbation studies: to reveal how human diseases are 
connected with genes, and to find improved treatments through our understanding of key 
regulatory mechanisms.  
With the development of small RNA gene knockdown technologies such as siRNA and 
shRNA, genetic perturbation assays are now possible on an unprecedented scale. However, the 
data from these experiments have only been partially interpreted due to the limited number of 
transcriptional regulations that are generally covered in pathway-based analyses. These pathway-
based analyses tend to suffer from limitations. For example, since genes interact through 
complex, highly interconnected pathways, knowing the immediate effect of a specific 
perturbation is not enough to predict its downstream consequences. This is of relevance for many 
drugs which may produce many negative side effects due to downstream effects on genes or 
gene products that do not belong to the predicted target pathway. These limitations can cause 
severe problems and failure of therapeutic strategies.  In addition, even though many studies 
have explained intra-phenotype gene dynamics, their results have not been easily reproducible. 
This is likely due to variations in experimental conditions, which can lead to different gene 
signatures or biomarkers. To overcome these limitations, the activity of every gene in the context 
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of the experiment should be taken into consideration, and when a gene or gene product is 
involved in perturbation experiments, its cause and effect should be considered in a genome-
wide manner. I would say the main weakness of the studies so far is their depth rather than 
breadth – so the things missing are dynamics of gene regulation and still our basic understanding 
of what is connected to what is not fully elucidated on a genome-wide scale.  
Because genome-wide reconstructed regulatory networks are supposed to accurately 
mimic real cellular mechanisms, network-based predictions enable us to explain how the effect 
of perturbation propagates through given network and to elucidate what master drivers induce 
the transition between normal and disease-related phenotypes in the cell.  Also, more 
sophisticated networks can more closely mimic real cellular mechanisms and can help us analyze 
more precisely the cause of variation and the effects of perturbation. 
In Chapter 2, I will discuss the hARACNe algorithm which enables us to reconstruct 
more sophisticated transcriptional regulatory networks. This algorithm is an upgraded version of 
the well-established ARACNe algorithm (Margolin, Wang, Lim, et al.; Margolin and Califano; 
Margolin, Wang, Califano, et al.) that uses transcription factor (TF) mRNA expression as a 
proxy of its TF protein activity. The original ARACNe algorithm applied the first-order data 
processing inequality (DPI) principle to detect and prune cascading transcriptional activities, also 
known as indirect interactions. However, a generalized DPI has been established by modern 
information theory. We therefore propose an upgraded network reconstruction method that uses 
higher-order DPI in the network reconstruction process. Using ChIP-on-chip data and expression 
profiles following TF silencing, we show that networks elucidated by recursively applying 
higher-order DPI, have higher accuracy than those of the original ARACNe algorithm. This 
upgraded network construction approach provides an improvement on the inference of true 
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positive functional feed-forward loop interactions in regulatory networks, and prunes indirect 
interactions separated by greater distances in cascading transcriptional regulations.  
In Chapter 3, post-translational modulation will be described. The transcriptional 
activities of TFs in the mammalian cell are mediated by a variety of cellular mechanisms, 
including, among others, phosphorylation and acetylation, formation of active complexes with 
one or more cofactors, and mRNA/protein degradation and stabilization processes. 
Transcriptional interactions in the cell are thus modulated by a variety of mechanisms that 
prevent their representation as a list of pairwise interactions between TFs and their target genes 
(TGs). The first attempt to computationally infer the activities of genes that modulate the 
activities between TFs and their targets was made by the MINDy algorithm (Kai Wang et al.; K. 
Wang, M. J. Alvarez, et al.). The MINDy algorithm predicts the activities of modulators (Ms) by 
identifying multivariate statistical dependencies between a transcription factor and its targets,  in 
the presence or absence of a candidate modulator gene. However, the metric used in identifying 
modulators, delta mutual information (dMI), is not able to detect many modes of modulator 
action, and also depends highly on pairwise mutual information (MI) between TFs and their 
targets. To overcome these limitations I propose the coMINDY algorithm, which uses the co-
information (interaction information) metric, and is able to successfully identify modulators in a 
way that is both mode-free and TF-TG dependency-free. 
In Chapter 4, I will describe the predictive simulation of regulatory networks for the 
genome-wide effects of perturbation.  There have been many attempts to predict the effects on 
given target genes when an upstream of gene is perturbed within a pathway. However, these 
approaches have only been marginally successful. In cases where the genes in the underlying 
pathway are not heavily intertwined with other pathways or regulatory networks, the methods 
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have an acceptable level of predictive performance. However, the most interesting genes are 
often highly coupled in pathways that are densely interconnected. To overcome these limitations, 
the regulatory network must capture the upstream components and downstream targets of every 
gene.  My simulations model the direct and indirect propagation of changes caused due to the 
perturbation of a single gene through a network. Because a downstream target gene in a sub-
network can function as a regulator of other sub-network, the method uses an iterative 
framework in order to capture the mixture of direct and indirect effects caused by the 
perturbation. Also, since there can also be random effects of gene set enrichment analysis 
(GSEA) (Abatangelo et al.; Kim and Volsky; A. Subramanian et al.; Aravind Subramanian et 
al.), we applied the random network approach in order to give more statistical power to our 
performance test. The method therefore uses a cascading performance test by first calculating the 
normalized enrichment score (NES) using GSEA or parametric weighted enrichment analysis 
(PWEA) (Alvarez), and then doing a z-test against NESs from random networks. 
In Chapter 5, we will build the inverse of the problem studied in Chapter 4, which is to 
predict the cause of the genome-wide phenotypic variation using the regulatory network. If the 
given predictive system in Chapter 4 performs well, we can utilize this system in the opposite 
fashion to predict which master driver is the cause of genome-wide phenotypic variations. All 
predefined TFs and Ms will be considered as the candidate targets of  a master regulator 
(Lefebvre et al.; Lim, Lyashenko and Califano). In Chapter 4, a regression model showed that 
the model’s convergence depends highly on the constraining method of Markov blanket (MB) 
after a large number of iterations.  Also, the model’s performance depends highly on outliers. In 
contrast, the Bayesian model is robust to noise and outliers and is not affected by the 
constraining method of MB. Additionally, this Bayesian model always converges after a smaller 
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number of iterations than its benchmarking models. Therefore, only the Bayesian model will be 
considered and its performance will be tested against the rank of normalized enrichment scores 





Building sophisticated transcriptional regulatory networks 
2.1  Introduction 
Genes can be classified based on their known biological functions.  However, these 
functions are rarely performed by single genes acting independently (Barabasi and Oltvai).  A 
pathway can be defined as a set of genes that act either upstream or downstream of a given 
function.  Some researchers have developed computational methods to find new functions or to 
improve our understanding of known pathways (Aoki-Kinoshita and Kanehisa; Honda et al.; 
Kanehisa and Goto; Ashburner et al.). Others have used approaches based on systems biology to 
reveal regulatory mechanisms as a mixture of all possible functions (Croft et al.; D'Eustachio; 
Joshi-Tope et al.; Matthews et al.; Stein). There has been particular interest focused on 
transcriptional regulation, because the mRNA transcript is the initial and minimal functional unit 
of a gene and is readily measurable using microarray-based approaches. Systems biology 
approaches are not just a collection of mathematical equations that model cellular behaviors, but 
have the potential to integrate multiple analyses from different data sources.  By doing so, the 
methods help identify key players in transcriptional processes.  
Thanks to modern high-throughput technologies such as microarrays, a large amount of 
gene expression data have been generated and profiled in various diseases, and biological 
contexts. These data have been extensively analyzed by reverse-engineering approaches to reveal 
transcriptional regulatory networks at the genomic scale (Butte and Kohane; D'Haeseleer et al.; 
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D'Haeseleer, Liang and Somogyi; Hartemink et al.; Imoto et al.; K. Basso, A. A. Margolin, et al.; 
Margolin, Wang, Lim, et al.; Gardner et al.; di Bernardo et al. "Chemogenomic Profiling on a 
Genome-Wide Scale Using Reverse-Engineered Gene Networks"; Friedman et al.).  Many 
models have been generated, and can be categorized into four distinctive groups: 1) 
coexpression-based networks, 2) Ordinary differential equations, 3) Bayesian networks, and 4) 
information theoretic approaches. A brief description of the advantages and disadvantages of 
these four models are described below.  
From the viewpoint of the reverse-engineer, the co-expression-based approach is not a 
network inference algorithm. Coexpression-based networks begin with the assumption that co-
expressed genes are likely to be functionally related. Associations between genes are measured 
by a distance metric such as a correlation coefficient. Using their computed distances, genes are 
clustered into groups. However, one shortcoming of this approach is that co-expression does not 
guarantee functional similarity.  The causal relationships between genes also cannot be identified 
and it is impossible to determine whether co-expressed genes are directly or indirectly connected. 
Despite these limitations, co-expression-based clustering is still one of the most popular 
approaches used to analyze microarray data. 
The Bayesian network (BN) is a more sophisticated method than co-expression-based 
clustering. BN is a directed acyclic graph (DAG) where each variable is supposed to be 
independent of its non-descendants. It is a graphic model that measures the probabilities among a 
set of genes as random variables, Gi{ } , where i =1,2,…,N . These relationships are represented 
as a joint distribution, P(G1,G2,…,GN ) . The joint distribution can be represented using the total 
probability theorem (or chain rule) as follows; 
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P(G1,G2,…,GN ) = P(Gi |Gi−1,…,G1)
i=1
N
∏ 	   	   	  	  	  	  	  	  	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  Equation	  2-­‐1	  
BN models identify a network topology as a DAG that best represents the expression data (D). 
Therefore, an objective scoring function is needed to evaluate each graph (G). Strictly speaking, 
it is impossible to optimize all gene combinations to find out the best G. Ad-hoc optimization 
methods, such as the greedy algorithm or the Markov Chain Monte Carlo (MCMC) methods are 
used for topology selection. BNs have a number of attractive features such as the ability to 
handle incomplete data well and avoid over-fitting the model with the training data. The method 
also has several disadvantages: because of the DAG structure, BNs do not allow feedback loops, 
even though these exist in real regulatory networks. Dynamic BNs partially solved this problem 
by separating input nodes from output nodes, allowing genes to be represented by both their 
regulators and their targets (Yu et al.; Perrin et al.).  However, the probabilistic dependency 
between genes does not always mean causal relationships and there is no way to distinguish 
direct and indirect interactions in BNs. Despite these limitations, BNs remain one of the most 
popular models used in reconstructing regulatory networks (Hartemink et al.; Perrin et al.; 
Friedman et al.). 
Gene regulatory networks can also inferred by using ordinary differential equations 
(ODEs).  ODEs describe gene expression changes as a function of other genes and external 
perturbations with the following equation: 
 gi (t) = fi (gi,gi,…,gi,µ,εi, t −1)        Equation 2-2 
where εi  is a set of parameters describing the interactions among genes, gi (t)  is the expression 
of the ith  gene at time, t , along with the external perturbation to the system, µ . Network 
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inference is described as the identification of function, fi , and the estimation of the unknown 
parameters, εi . An advantage of ODE is that once the parameters, εi , for all i  are known, the 
behavior of the network can be quantitatively predicted under various different conditions. 
However, because of the large amounts of training data required for ODEs, this approach was 
mainly applied to the reconstruction of relatively small sub-networks. Recent applications that 
use ODEs are Network Identification by multiple Regression (NIR) (Gardner et al.), Microarray 
Network Identification (MNI) (di Bernardo et al. "Chemogenomic Profiling on a Genome-Wide 
Scale Using Reverse-Engineered Gene Networks"), and Time Series Network Identification 
(TSNI) (Bansal and di Bernardo). 
In my research, an information theory approach using mutual information (MI) was 
applied to detect the pairwise dependencies between genes (K. Basso, M. Saito, et al.; Butte et 
al.; Ram and Chetty; Margolin, Nemenman, et al.; Reis, Butte and Kohane), 
 I(X;Y ) = H (X)+H (Y )−H (X,Y )        Equation 2-3 
where the entropy function, H , is defined as Equation 2-4; 
 H (X) =
− p(x)log p(x)( )dx    in continuous case∫
− p(xk )log p(xk )( )k=1
N






.     Equation 2-4 
A higher MI value indicates that the two genes are not randomly associated, whereas when MI is 
zero, it means that expression of two genes is statistically independent. The early implementation 
of using information theory to reconstruct networks was known as a relevance network (Butte 
and Kohane). However, the interactions predicted by relevance networks contained a large 
number of false positives and the edges were undirected. ARACNe (Algorithm for the 
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Reconstruction of Accurate Cellular Networks) was also developed based on information theory, 
but solved the limitations of relevance networks by applying both predefined TF lists and data 
processing inequality (Margolin, Wang, Lim, et al.). ARACNe used a pre-defined TF list as a set 
of candidate regulators and MIs were computed between TF and all other genes in given gene 
expression profiles(GEP). This strategy enabled identification of the causal relationship between 
TFs and their targets. Another significant improvement in ARACNe, distinguishable with 
relevance network, was to apply data processing inequality (DPI), which enabled detection of 
false positive feed-forward loops within three neighboring genes (triplets). The rationale was that 
if a given triplet forms a Markov chain X→Y → Z , then both X→Y  and Y → Z  must be 
directly interacting, whereas X→ Z  is indirectly connected despite its significant MI. Thus, 
when satisfying DPI, I(X;Z ) ≤min I(X;Y ), I(Y ;Z ){ } , the weakest link in the triplet, X→ Z , is 
identified and filtered.  ARACNe was therefore able to eliminate these false positive interactions. 
ARACNe has been discussed in more detail by other authors (Margolin, Wang, Lim, et al.; K. 
Basso, A. A. Margolin, et al.) and in the Materials and Methods section. 
ARACNe was specifically designed to scale up to the complex regulatory networks in 
mammalian cells, yet be general enough to address a wider range of network deconvolution 
problems. ARACNe has been shown to work well for reconstructing large-scale regulatory 
networks using microarray expression profiles. Basso et al (K. Basso, A. A. Margolin, et al.) 
used ARACNe to reverse engineer the regulatory network for human B-cells and showed that 
MYC targets identified by ARACNe were highly accurate and directly regulated by MYC. This 
algorithm was also used to build the transcriptional network for mesenchymal transformation of 
brain tumors (Carro et al.), and a human B-cell interactome was built based on ARACNe as well 
as identification of the master regulators of proliferation in germinal-center B cells (Lefebvre et 
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al.; Lim, Lyashenko and Califano; Carrera, Rodrigo and Jaramillo). These studies show that 
ARACNe is one of the most reliable algorithms in reverse engineering. 
Three different approaches have been used to improve the ARACNe algorithm: 
biological, computational, and statistical. Due to the lack of genome-wide protein activity 
measurements, ARACNe and other reverse engineering algorithms have utilized mRNA 
expression levels as a proxy to the activity of the corresponding activity of a protein encoded by 
its corresponding gene. In reality, however, it is known that a large number of post-
transcriptional regulations exist which influence the relationship between mRNA and protein 
activities. These include mRNA splicing, mRNA stability, microRNAs, and modifications to the 
protein itself (Fu et al.; Lee et al.; Day and Tuite; Chen and Rajewsky; Filipowicz, Bhattacharyya 
and Sonenberg). Thus, iARACNe was proposed (Zhou), which addressed this biological issue by 
first predicting TF protein activity from a first round of reverse engineering and then using the 
inferred activity of the TF in place of its mRNA expression in one or more subsequent target-
inference rounds. In order to save computing costs in the calculation of the MI, adaptive 
partitioning was implemented in ARACNe2. The application of bootstrapping was able to make 
the inferred predictions more statistically powerful and reliable. 
Despite the fact that modern information theory has extended the DPI concept into more 
than three Markovian connections, the main core of ARACNe algorithm, DPI, has been limited 
to triplets.  In this research, we propose a post-processing algorithm, named hARACNe (higher-
order ARACNe), which is able to detect higher-order false positive feed-forward loops and 
eliminate them.  Our results show that this sort of  ‘global’ post-processing of higher-order DPI 
(Han et al.; Cover) may be recursively applicable to the results of any ARACNe networks with 
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static, time-course, even post-transcriptional updated data (Margolin, Nemenman, et al.; Zoppoli, 
Morganella and Ceccarelli).  
The results of ARACNe and hARACNe were compared by computing both true positive 
gain/loss and false positive gain/loss. This was done by comparing all inferred interactions to 
known gold standard interactions in ChIP-chip and siRNA libraries. Comparison of results 
between ARACNe and hARACNe show that 10-30 percent of inferred interactions identified in 
ARACNe might be identified as indirect interactions by hARACNe algorithm, which is because 
hARACNe systematically detects potential false positive feed-forward loops. These performance 
values were evaluated by the gain and loss of true and false positive target genes of MYC(ChIP-
on-chip experiments) and BCL6 (differentially expressed genes by siRNA) (Basso; Katia Basso 
et al.; K. Basso, M. Saito, et al.). In both cases, hARACNe led to a dramatic decrease in false 
positives over ARACNe. In summary, the new algorithm improves ARACNe’s performance by 
detecting indirect interactions with higher orders than triplets. There are two novel aspects of our 
method; first, the method can be applied regardless of data type; and second, the method 
considers more sophisticated transcriptional regulations during network reconstruction and this 





2.2 Materials and Methods 
2.2.1 Data sources 
Leukemia, lymphoma, myeloma and myelodysplastic syndromes (MDS) are types of cancer 
that can affect the bone marrow, the blood cells, the lymph nodes and other parts of the 
lymphatic system. These cancers are all related since each is likely to result from acquired 
changes to the DNA of a single stem cell. An estimated combined total of 137,260 people in the 
United States will be diagnosed with leukemia, lymphoma or myeloma in 2010. New cases of 
leukemia, lymphoma and myeloma will account for 9 percent of the 1,529,560 new cancer cases 
diagnosed in the United States this year. Among the sixteen sites of the body considered, 
leukemia was the 12th most common class of neoplastic disease, and the 11th most common 
cancer-related death (Leukemia & Lymphoma society). 
Leukemia is the second most common form of cancer in infants under the age of 12 months, 
and the most common form of cancer in older children. Boys are somewhat more likely to 
develop leukemia than girls, and white American children are almost twice as likely to develop 
leukemia as black American children. Leukemia, lymphoma and myeloma will cause the deaths 
of an estimated 54,020 people in the United States in 2010. These account for nearly 9.5 percent 
of the deaths from cancer in 2010, based on the total of 569,490 cancer deaths (Leukemia & 
Lymphoma society; Armstrong et al.). 
For this study, the 254 GEPs were collected from 17 distinct B cell phenotypes including 
normal B cells as well as primary tumors and tumor-derived cell lines. An additional, distinct B-
cell leukemia dataset included 226 samples from B-cell phenotypes including naïve, memory and 
germinal center B cells isolated from human tonsils and from B cell tumors including diffuse 
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large B cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia 
(CLL).  Both B Cell datasets used HG-U95Av2 and HG-U133 Plus2.0 GeneChips (Affymetrix) 
(Katia Basso et al.; K. Basso, M. Saito, et al.; Lefebvre et al.; Kartik M. Mani et al.; Margolin, 
Nemenman, et al.; Kai Wang et al.). The data discussed in this research have been deposited in 
the Gene Expression Omnibus (GEO; National Center for Biotechnology Information) and are 
accessible through GEO Series accession numbers GSE2350 and GSE12195. The list of 
phenotypes is found in Table 2-1. 
Table 2-1. Human B cell phenotypes in the two GEPs  
HG-U95 Av2 HG-U133 Plus2.0 
Diffuse large B-cell lymphoma 68 Naïve B-cell 5 
Burkitt's lymphoma 33 Memory B-cell 5 
Follicular lymphoma 14 Germinal center B-cell 11 
Mantle cell lymphoma 8 B-cell chronic lymphocytic leukemia 16 
B-cell chronic lymphocytic leukemia 34 Follicular lymphoma 38 
Hairy cell Leukemia 16 Diffuse large B-cell lymphoma 128 
Multiple myeloma 4 Undefined 23 
Hodgkin’s lymphoma 4   
Primary effusion lymphoma 9   
Splenic lymphoma with villous lymphocytes 12   
Large cell lymphomas 5   
Burkitt's lymphoma type III 3   
Undefined 2   
Germinal center B-cells 17   
Naïve B-cell 5   
Memory B-cells 5   
Cord blood 5   




2.2.2 Data pre-processing procedure 
Due to the high level of variability in the human B cell datasets, we initially transformed 
the data into a modified log2 scale using the following equation. 
 x = log
2
X +1( )          Equation 2-5 
where X  represents the MAS5 normalized mRNA expression level of gene Gx  and x  is the 
modified log2-transformed expression level. Usually, gene expression levels are log2-
transformed and are considered 2-fold changes. However, expression levels less than 1 should be 
meaningless but after log2-transformation they severely affected training coefficients in 
regression models and were considered to be outliers.  These outlier effects, which add 
unexpected biases to the data, are eliminated by simply adding one.  
When considering iterative frameworks, which will be covered later, y-intercept 
coefficients in the regression model have cumulative effects during simulations (Chapter 4). To 
reduce this cumulative effect by y-intercepts, the training data could be shifted using the global 
mean  as follows; 
 






∑       Equation 2-6 
where sTR(x, y)  is the global mean shifted expression level of the xth gene in the yth sample in 
the training data (TR ). is the total number of genes in the GEPs and Y  is the total number of 
samples in given GEPs. The rationale for global mean shifting will be described later when 




The data processing inequality (DPI) is a simple but powerful theorem that in essence 
states the following: no matter what processing you do to set of data, you cannot get more 
information than was there to begin with. In a sense, it provides a boundary on how much can be 
accomplished with signal processing. A Markov chain is at the heart of the ``state'' idea in 
differential equations and is used commonly in controls. The concept of a state is that knowing 
the present state, the future of the system of independent of the past. In other words, the state 
provides all the information necessary to move into the future: the necessary initial conditions of 
the differential equations (Cover; Han). 
A first-order DPI calculation is used to remove the weakest interaction among three 
consecutive markers. If MI values are available between each of three possible pairings of three 
nodes, the weakest interaction out of the three will be removed from the output. This serves to 
remove indirect interactions. For example, if X→Y → Z , the indirect interaction X→ Z  will 
likely be weaker than X→Y  or Y → Z  and would be removed with the following formula; 
I(X;Z ) ≤min I(X;Y ), I(Y ;Z ){ }         Equation 2-7 
 




Figure 2-2.  2nd order DPI recursive procedure to detect indirect interaction in quadruplet 
 
To extend DPI to a higher order, a Markovian quadruplet is first considered. When four 
random variables, X, Y, Z, and W, make a Markov chain in the following order, 
X→Y → Z→W , we have the second-order DPI formula as follows; 
 I(X;W ) ≤ I(Y ;Z )                 Equation 2-8(a) 
Proof : It follows from the Markov property satisfying conditional independency among triplets 
as I(X;W |Y ) = I(Y ;W | Z ) = 0 . Therefore, by repeatedly using the chain rule, 




I(X;W ) ≤ I(X,Y ;W )
             = I(Y ;W )+ I(X;W |Y ) = I(Y ;W )
             ≤ I(Y;ZW)
             = I(Y ;Z )+ I(Y ;W | Z ) = I(Y ;Z )
 .                      Equation 2-8(b) 
Figure 2-2 shows how the 2nd order DPI is recursively applied in order to detect false positive 
feed-forward loops within a Markovian quadruplet.  
Next, five Markovian markers are considered as random variables after applying 2nd 
order DPI. With the assumption of a Markov chain with the order of  X→Y → Z→W →V , we 
can apply the third-order DPI with conditional independency among connected triplets and 
quadruplets and derive the following formula;  
 
I(X;V ) ≤min I(X;Z ), I(Z;V ){ }
I(X;W ) ≤ I(Y ;Z )
I(Y ;V ) ≤ I(Z;W )
.                 Equation 2-9 
The recursive procedure from 1st order to 3rd order DPI is described pictorially in Figure 2-3.  
Finally, we can extend the DPI into the fourth-order DPI, where Markovian sextuplets act 
as random variables after recursively applying 2nd order and 3rd order DPI. With the assumption 
of a Markov chain with the order of  X→Y → Z→W →V→U , we can apply the fourth-order 
DPI with conditional independency among connected triplets, quadruplets, and quintuplets and 
derive the following formula with Equation 2-7, Equation 2-8, and Equation 2-9;  
 
I(Y ;V ) ≤ I(X;U)
I(X;U) ≤ I(Z;W )





Figure 2-3. 3rd order DPI recursive procedure to detect indirect interaction in quintuplet 
 
Figure 2-4. 4th order DPI recursive procedure to detect indirect interaction in sextuplet 
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We also searched for Markovian sextuplets in the improved ARACNe network, which 
already prunes Markovian triplets, quadruplets, and quintuplets. Figure 2-4 shows the final 
decision process after recursively applying 1st order, 2nd order, and 3rd order DPI.  
Thus, applying the chain rule recursively from three to more Markovian markers makes it 
possible to prune indirect interactions (i.e. false positive feed-forward loops) from the network 
inferred by ARACNe. This recursive algorithm may be applicable to any modified versions of 
ARACNe algorithm which use the DPI to prune indirect interactions. Networks inferred from 
other types of data including time-course GEPs and metabolic data, may become more 
sophisticated by applying higher-order DPI and pruning indirect interactions of higher-order.  
  
2.2.4 ChIP-chip data and siRNA studies 
Over the past few years, the analysis of protein-DNA interactions has evolved from 
single-locus chromatin immunoprecipitation (ChIP) analysis to the analysis of DNA-binding 
sites at a genomic scale by combining ChIP assays with microarray analysis (Hudson and 
Snyder). Because this approach combines ChIP and DNA microarrays, it has conventionally 
been referred to as ChIP-chip. ChIP-chip combines a classic ChIP protocol with DNA 
microarray analysis to allow the detection of protein-DNA interactions in a non-biased way with 
genome-wide coverage (Weinmann and Farnham; Weinmann et al.). In the method, ChIP-
purified DNA is amplified, fluorescently labeled and hybridized to DNA microarrays containing 
genomic DNA sequences along or in parallel with a control DNA sample corresponding to the 
total (non-immunoprecipitated) genomic DNA. Using ChIP-chip, it is possible to interrogate the 
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pattern of binding of a DNA-binding protein of interest through all non-repetitive DNA 
sequences in the genome (Margolin, Palomero, et al.; Palomero and Ferrando). 
RNAi has emerged as one of the most powerful genetic tools for the dissection of gene-
regulatory networks. The implementation of RNAi technology in mammalian cells by either 
short interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs) has made the selective 
knockdown of gene expression possible (Berns et al.; Brummelkamp et al.; Brummelkamp and 
Bernards; Brummelkamp, Bernards and Agami; Paddison, Cleary, et al.; Paddison, Caudy, 
Sachidanandam, et al.; Paddison, Silva, et al.; Paddison, Caudy, Bernstein, et al.; Schaniel et al.; 
Silva et al.; Sandy, Ventura and Jacks). However, RNAi experiments must take into account 
potential limitations of this technology (Sandy, Ventura and Jacks): 1) The experiments require 
the identification of si/shRNA sequences that effectively reduce target gene expression, and 2) 
require verification of the specific knockdown of the targeted gene, with minimal off-target 
effects. One of the most exciting potential applications of RNAi technology is in mammalian 
somatic cell genetics (Shaffer, Wright, et al.). In this approach, libraries are created to express 
shRNAs targeting thousands of genes, and screens are conducted to identify which si/shRNAs 
target genes that control a specific cellular phenotype. In addition, the identification of shRNA 
that knocks down gene expression by more than 50% (more than 2-fold changes) has enabled 
researchers to observe the phenotypic changes between control and treated B cells.  
Ramos and Mutu Human Burkitt's lymphoma cell lines were used in the ChIP-chip 
experiments for predicting targets of MYC protein binding. ChIP-on-chip Significance Analysis 
(CSA) was applied, where p-values were first derived for each probe from three replicate 
experiments.  These p-values were then combined for each 500-base promoter segment using a 
Gamma cumulative distribution function. Each promoter was associated with the highest 500-
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base MYC-localization segment, and the false discovery rate was computed using the Benjamini 
Hochberg procedure, as a function of gene rank. In addition, LY7 (DLBCL), PFEIFFER 
(DLBCL for studying non-Hodgkin lymphomas), and VAL (ALL) cell lines were used for BCL6 
knockdown experiments using siRNAs because BCL6 is believed to mediate the germinal center 
B cell phenotype and lymphomagenesis through transcription repression.  
Thus, differentially expressed genes were first identified from BCL6 knock-down 
experiments (FDR < 0.05). ARACNE and hARACNe regulons (i.e., BCL6 targets) of BCL6 
were then compared to the differentially expressed genes by detecting true/false positive gain, 




,               Equation 2-11  
where TP is the number of overlapping genes between the (h)ARACNE regulon of a given TF 
and the set of differentially expressed genes, and FP is the number of genes in (h)ARACNE 
regulon but not found in the set of differentially expressed genes. 
 
 




2.3.1 Reverse engineering transcriptional networks with standard ARACNe and 
hARACNe 
The number of transcriptional interactions in the reconstructed networks was compared, 
and the distributions how many targets TF has were shown in Table 2-2. When the human B cell 
data  from the Affymetrix U95 platform (REFERENCE OF DATASET) was examined, there 
were 12600 probe IDs identified, of which 1,225 were for transcription factors representing 848 
unique genes given by Affymetrix annotation. The ARACNe (original ARACNe: oA) identified 
155526 transcriptional interactions at the level of probe ID. After applying the second order DPI 
with oA, 134452 interactions (h1A) remained and 21074 were detected as indirect interactions, 
which ARACNe could not detect. When the third-order DPI was applied, 132018 interactions 
(h2A) remained and 2434 out of h1A were identified as indirect interactions within quintuplets. 
We also applied fourth-order DPI with (h2A) and detected 280 interactions, which were indirect 
interactions in sextuplets. Although we can recursively apply higher-order DPI, the application 
quickly reached its saturation point; this meant that the application of greater than fourth-order 
DPI only resulted in the detection of a few dozen further indirect interactions, along with  a very 
high computational cost. In the B cell dataset that was profiled using the Affymetrix U133 
platform (REFERENCE OF DATASET), there were 14090 probe ids, of which 1,290 were 
transcription factors representing 1209 unique genes. ARACNe (original ARACNe: oA) 
identified 198766 transcriptional interactions at the probe ID level. After applying the second 
order DPI with oA, 142037 interactions (h1A) remained, with 56729 being detected as indirect 
interactions.  When the third-order DPI was applied, 138697 interactions (h2A) remained, with 
3340 out of h1A being identified as indirect interactions within quintuplets. When we applied 
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fourth-order DPI with (h2A), 1533 interactions in h2A were identified as indirect interactions in 
sextuplets. As before, we did not apply higher-order DPIs for the sake of the computational 
efficiency.  
Within the B cell U95AV2 dataset (ADD REFERENCE OF DATASET), comparison of 
the interactions inside each network showed that 81.4% of the interactions in the oA network 
were also found in the h1A network, while 98.2% of interactions in the h1A network were found 
in the h2A network and 99.8% of interactions in the h2A network were found in the h3A 
network. Similarly, the result from the B cell U133P2 dataset showed that 71.5% of the 
interactions in the oA network were also found in the h1A network, while 97.7% of interactions 
in the h1A network were found in the h2A network and 98.9% of interactions in the h2A 
network were found in the h3A network. At this point, two questions came up.  First, why did 
there exist a saturation point in the filtration of the networks, after which the application of 
higher-order DPIs did not change the network significantly? Also how much better were the new 
networks generated by hARACNe than the one inferred by original ARACNe? To answer these 
questions, we evaluated our prediction functionally and statistically. See Figure 2-6 for more 
details. 





































Figure 2-6 Overall MI comparison between oA and h3A networks  
 
Every TF has its target genes identified by ARACNe and hARACNe. Although the TFs 
identified were the same, the number of edges they have changed depending on the method used. 
The distributions of differential number of edges between ARACNe and hARACNe are shown 
in Table 2-2. In the U95 dataset, ELK1 has 233 targets in ARACNe, whereas h1ARACNe 
identified 136 targets: Thus 97 interactions were pruned by second-order DPI. However, only 
seven out of 136 targets of ELK1 were recursively detected as indirect interactions by third-order 
DPI. There was no detection of indirect interactions after applying fourth-order DPI in ELK1 
targets. The same pattern was also observed in the B cell data with HG-U133 Plus2.0 GeneChip. 
The TF which had the largest difference in predicted number of targets 
by ARACNe and h1ARACNe was ZNF267. ARACNe inferred 223 targets of ZNF267,  
26 
 
whereas 102 targets were identified by h1ARACNe (121 interactions between ZNF267 and 
inferred targets were pruned by second-order DPI). 91 and 86 targets remained after third-order 















































































































2.3.2 Functional Validation with ChIP-chip for MYC regulons from hARACNe and 
ARACNe 
The MYC gene and its gene product (MYC protein) is believed to regulate more than 
15% of all known human genes (Gearhart, Pashos and Prasad). MYC has been known to bind to 
E-boxes in the promoter regions of target genes, and in addition to this role as a classical 
transcription factor, MYC also regulates global chromatin structure by manipulating histone 
acetylation both in gene-rich regions and at sites far from known target genes (Cotterman et al.). 
A mutated version of MYC is found in many cancers, which causes MYC expression to be 
persistent. The mutation leads to the unregulated expression of many genes some of which are 
involved in cell proliferation and results in the formation of cancer (Soucek et al.). A 
translocation of MYC is commonly involved in the development of Burkitt's lymphoma. A 
recent study showed that MYC inhibition selectively kills mouse lung cancer cells, which means 
MYC might be a cancer drug target (Soucek et al.). 
 





All the interactions predicted in hARACNe and original ARACNe were functional 
relationships between TFs and target genes, based on the correlations of their mRNA expression 
levels. ChIP-based approaches detect the physical interactions between TFs and their target 
genes by locating the TF binding sites on the target genes. Theoretically, true positive  
interactions should be among ones which are identified by both functional prediction and 
physical prediction. ChIP-chip experiments directly measures TF interactions, and will therefore 
provide validation of TF target pairs identified in ARACNe.  
In order to evaluate the computational improvement provided by hARACNe, a gold-
standard was used.  The gold-standard dataset was composed of Ramos and Mutu (Human 
Burkitt's lymphoma) cell lines which were used in ChIP-chip experiments for revealing MYC 
protein binding targets(Margolin, Palomero, et al.). ChIP-on-chip Significance Analysis (CSA) 
was applied: probe p-values were derived from three replicate experiments and combined for 
each 500 base pair promoter segment using a Gamma cumulative distribution function. Each 
promoter was associated with the highest 500 base pair MYC-localization segment, and the false 
discovery rate as a function of gene rank was computed using the Benjamini Hochberg 
procedure. This approach led to the prediction of 5307 and 3310 putative MYC binding targets  
in Ramos and Mutu cell lines, respectively. We then analyzed the reconstructed MYC sub-
networks in the CHIP-chip dataset using ARACNe. In the Ramos cell line, only five true positive 
MYC targets were discarded by applying recursively higher-order DPI up to fourth-order, 
whereas 13 false positive MYC targets were identified and discarded. Similarly, four true 
positive MYC targets in the Mutu cell line were falsely identified as indirect interactions. 
However, 14 indirect downstream of MYC were successfully detected.  Thus, the number of true 
positive MYC targets discovered by both ARACNe and hARACNe did not change significantly, 
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whereas the number of false positive targets decreased significantly using hARACNe (see Table 
2-3). Therefore, hARACNe shows network inference improvement in precision and accuracy.  
2.3.3 Differentially expressed gene signatures from siRNA library for BCL6     
In section 2.3.1, it was shown that hARACNe reconstructed networks (h1A, h2A, and 
h3A) had fewer interactions when compared to the networks reconstructed by original ARACNe 
(oA). To check whether or not this decrease in interactions improved the accuracy of  network 
prediction, one gene was selected and knock-down experiments were performed in the lab.  
BCL6 has been known to play an important role in lymphoma and leukemia, and was 
recently identified as one the master regulators of B cell lymphomas (Basso and Dalla-Favera). 
BCL6 is an oncogene which is frequently activated in human B cell lymphomas, most of which 
derive from the germinal-center B cells. A thorough understanding of the biological role of 
BCL6 in normal B cell development and lymphomagenesis depends upon the identification of 
the full set of its transcriptionally regulated target genes. Recently, the identification of BCL6 
targets has been implemented with the use of genome-wide chromatin immunoprecipitation and 
reverse engineering approaches using gene expression profiles (GEPs). The BCL6 targets 
identified are involved in a number of cellular functions which are likely to be directly controlled 
by BCL6 during GC development. These functions include activation, survival, DNA-damage 
response, cell cycle arrest, cytokine-, toll-like receptor-, TGFβ-, WNT-signaling, and 
differentiation (Niu, Cattoretti and Dalla-Favera; Polo et al.; Shaffer, Yu, et al.; Ranuncolo et 
al.). 
Data from the siRNA experiments was used to validate the efficiency of hARACNe 
compared with ARACNe. After BCL6 siRNA treatment, statistically significant differentially 
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expressed genes were used as gold standard targets of BCL6. Knockdown was performed using 
DLBCL and CLL cell lines (LY7, PFEIFFER, and VAL) infected with control siRNA or siRNA 
targeting BCL6. RNA extracted from knocked down cells was analyzed by a microarray using 
Affymetrix HG-U95A chips. Differentially-regulated genes were identified using fold-change 
criteria and p-value thresholds determined using a nonparametric U test. These were 
automatically preset to identify differentially expressed genes at or below 0.05 false discovery 
rates. In LY7, PFEIFFER, and VAL cell lines, 1507, 3706, and 3199 differentially expressed 
genes (gene signature) were identified, respectively. The comparison among oA, h1A, h2A, and 
h3A networks showed that the true positive set of BCL6 targets inferred by ARACNe and 
hARACNe was almost identical, but hARACNE was able to detect significantly more false 
positive targets (Table 2-4), where gain and loss were computed between ARACNe (1st order 
DPI) and h3ARACNe (4th order DPI). 
 






The goal of this work was to improve a well-known reverse engineering algorithm, 
ARACNe. In doing so, we sought to make systematic improvements that would increase our 
understanding of transcriptional mechanisms. I have been working with perturbation studies as a 
way of computationally predicting the effects of genetic perturbations on a genome-wide scale.  I 
have also been developing methods to identify the master drivers that produce phenotypic 
changes.  Answering these questions requires the effective identification of interactions between 
TFs and their target genes. Is it possible that this question might be addressed computationally, 
using a regulatory model?  Clearly, the assembly of reliable transcriptional regulatory network 
models would allow the study of each TF and the targets that it regulates. The goal of this 
research is to improve the accuracy of transcriptional regulation network models by applying a 
mechanistic understanding of TF-target regulation.  
hARACNe addresses this challenge by using an ARACNe network as an initial step, and 
pruning indirect interactions between TFs and their targets by using higher order DPI. This 
allows the algorithm to filter more distant indirect-interactions. Since ARACNe has been shown 
to infer accurate gene regulatory networks for mammalian cells, the initial ARACNe network 
constitutes a reasonable starting point to apply higher-order DPI for a more refined network. 
To evaluate the networks constructed by hARACNe and ARACNe, they were compared 
multiple gold standards such as ChIP-chip results and microarray data from siRNA knockdown 
experiments. Analysis of gene expression profiles after siRNA knockdown of  BCL6 showed 
that BCL6 target genes from the hARACNe network had significantly less false positive 
predictions when compared to ARACNe. A similar improvement in the false positive predictions 
was shown in hARACNe than ARACNe by comparing to the known interactions predicted by 
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ChIP-chip experiments ofMYC targets. Overall, it was demonstrated that by introducing 
recursive higher order DPI into network reconstruction, we could reconstruct a more reliable 
network, when compared to the results of applying first-order DPI.  
However, there are a few computational limitations in hARACNe. First, because 
hARACNe begins with the ARACNe network and recursively applies higher order DPI, it 
performs calculations on a great number of subnetworks. Therefore, the method requires 
significant computational resources. Second, even if the method were to recursively apply higher 
order DPI, the computational efficiency would drop drastically. The results showed that second 
order DPI identified indirect interactions most efficiently, and DPI of higher-orders had 
significantly lower detection rates. Also, although the accuracy of the regulon increased, some 
known interactions might still be missed. Therefore, the best application for hARACNe is for 
researchers to identify the most reliable feed-forward loop candidates for further investigation.  
Currently, most network-inferring algorithms take microarray expression data as their 
inputs to reconstruct the network. Their assumption is that gene mRNA expression level can be 
used as a proxy to its protein activity. This assumption has always been questioned by biologists, 
because it is frequently violated in the cell. Post-translational (e.g. by kinases, phosphatases, 
ubiquitin-conjugating ligases), post-transcriptional (e.g., by microRNAs and mRNA binding 
proteins), and translational regulation (e.g., by ribosome binding proteins) break the direct link 
between the mRNA expression of a TF and its activity at the protein level.  Since there is no 
method that enables us to measure genome-wide TF protein activity, if mRNA should not be 
used as a direct proxy to protein activity, what should be used?  To obviate this problem, 
iARACNe algorithm was developed and iteratively inferred TF activity levels by using the 
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predicted TF’s target genes (Zhou). Nevertheless, iARACNe networks might be improved by 






Identification of post-translational regulatory networks 
3.1 Introduction 
Signal transduction pathways play a key role in regulating transcriptional activity in the 
nucleus as a function of inter-cellular communication networks. These are regulated through 
complex cascading post-translational modifications, thus determining cellular responses to 
external stimuli. Understanding of these pathways is increasingly important when dissecting 
human disease and identifying targets for therapeutic intervention (Gough "Science's Signal 
Transduction Knowledge Environment: The Connections Maps Database"; Gough "Signal 
Transduction Pathways as Targets for Therapeutics"), because signaling molecules (e.g., 
receptors and protein kinases) rather than transcription factors are much more effectively 
targeted by small molecules. Unfortunately, cell-context specific dissection of signaling 
pathways is still challenging because it is very difficult to measure protein levels and the amount 
of post-translational modification with high-throughput technologies. As a result, the dissection 
of signaling pathways is relatively slowly proceeding through limited protein-protein interaction 
(PPI) screens (Zhang et al.). 
In contrast, the availability of large collections of global gene expression profiles (GEP) 
(Roberts et al.) has fostered significant progress in the genome-wide dissection of transcriptional 
programs (Gardner et al.; di Bernardo, Gardner and Collins; Katia Basso et al.; Bansal, 
Belcastro, et al.; Bansal, Della Gatta, et al.; Bansal and di Bernardo; Carninci et al.; Cosentino et 
al.; di Bernardo, Bansal and Della Gatta). However, GEPs have not been widely used in the 
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dissection of post-translational interactions. Several GEP-based studies of yeast signal 
transduction networks have been limited to the identification of gene modules regulated by a 
small number of regulators, including some signaling proteins (Roberts et al.), or to the 
reconstruction of signaling pathways using known PPIs as a post-translational network topology 
(Steffen et al.). Nevertheless, a cell-context-specific map of the interface between signaling and 
transcriptional regulatory programs is still daunting in higher eukaryotes. 
The MINDy (Modulator Inference by Network Dynamics) algorithm was initially 
introduced for the genome-wide identification of post-translational modulators of transcription 
factor (TF) activity (Kai Wang et al.). This algorithm elucidates post-translational modulation 
events on transcriptional interactions, where a TF and its targets appear to only have a 
conditional interaction  due to the presence of a third party gene; a so-called modulator (M). 
MINDy tested whether the delta mutual information (dMI) as a proxy of conditional mutual 
information (cMI:
 
I(TF;TG |M )  ), between a TF and a target gene (TG), as a function of a 
modulator M is non-constant. In this case, M is inferred as a candidate post-translational 
modulator of the TF. Based on this analysis, MINDy could also determine whether the modulator 
protein would activate or repress the TF-target interaction, resulting in either a positive or 
negative mode of modulator actions (MoMAs).  
Designed to deconvolute post-translational networks genome-wide, MINDy was applied 
human B cell GEPs to reverse engineer the modulation network (Kai Wang et al.). This showed 
that predicted MYC modulator targets were highly plausible. This algorithm was also used to 
build the human B-cell interactome and identified molecular targets in the IDEA algorithm with 
very heuristic assumption about global modulators (Kartik M. Mani et al.).  
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These modulators need not directly interact with the TF or TG, but may regulate another 
gene or protein that subsequently interacts with downstream targets. It has been demonstrated 
that the existence of such a unique three-way interaction could be tested by the information 
theoretic quantity, differential entropy, which measures the reduction in entropy by constraining 
p(TF,TG,M )  as opposed to pair-wise joint probabilities. For entropy differences between given 
topologies, Wang et al found the entropy with two-dimensional joint distributions for topology 
(a) in Figure 3-1 as follows; 
pa (TF,TG,M ) =
p(TF,TG)p(M,TG)
p(TG)
⇔Ha (TF,TG,M ) ≈ H (TF,TG)+H (M,TG)−H (TG)
     Equation 3-1 
Because the distribution of the general three-way topology preserves its dimensionality, the 
potential entropy difference was derived as follows: 
 
Δ = Ha (TF,TG,M )−H (TF,TG,M )
  = H (TF,TG)+H (M,TG)−H (TG)−H (TF,TG,M )
  = I(TF;TG |M )− I(TF;TG)+ I(TG;M )
  ≡ I(TF;M |TG)
.     Equation 3-2  
However, based on the assumption of I(TF;M ) = 0 , the potential difference became co-
information, Δ ≅ I(TF;TG |M )− I(TF;TG) ≡ I(TF;TG;M ) . Furthermore, because I(TF;TG)
 
was 
treated as a constant with respect to M, the metric of MINDy was simplified and became the 
conditional mutual information (cMI), Δ ≈ I(TF;TG |M ) .  
Because a fixed bandwidth method was used to estimate the values of mutual 
information, estimating I(TF;TG |M )  as a function of M was extremely sample-size dependent 
and computationally intensive. However, inspired by a biological transistor model using realistic 
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biochemical kinetics, found that I(TF;TG |M )  was a monotonic function of M under a wide 
range of conditions. Therefore, assessing (Kai Wang et al.)
 
I(TF;TG |M )  could be turned into a 
much more modest task of estimating the difference between I(TF;TG)  at the two extremes of 
the expression range of M, which substantially reduced the data size requirement, since pair-wise 
mutual information(MI) could be estimated efficiently from relatively small datasets. More 
formally, under the assumption of monotonicity of modulator function, 
 
I(TF;TG |M )  became 
as follows; 
I(TF;TG |M ) ≅ I(TF;TG)+ − I(TF;TG)−
                      = I(TF;TG |M + )− I(TF;TG |M − )
.       Equation 3-3 
To assess the statistical significance of the ΔI  value computed using Equation 3-3, a 
series of null hypotheses were generated by measuring the  distribution with random 
conditions. Thus, the statistics of  were highly dependent on . The procedure to 
compute  is depicted in Figure3-2 and as its intrinsic limitations are caused by several 
assumptions and approximation process, the mode of modulator action (MoMA) is categorized 
in Table 3-1.    
As shown in Figure 3-1, a three way interaction might be differentiated into four sub-
categories with their roles. Although MINDy tried to cover case a shown in Figure 3-1, 
coMINDy was developed to find differently categorized modulators (cases b, c, and d in Figure 
3-1) using co-information. coMINDy had much less assumptions than the MINDy algorithm as 
follows:  I(TF;M) can or cannot be zero, and I(TF;TG) is not supposed to be constant. Because 
coMINDy used interaction information among TF, TG, and M, it might capture MoMA-free 
modulators, whereas MINDy modulators were strongly associated with a specific MoMA 
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because of its partial information and assumptions. Indeed, the newly proposed metric 
considered I(TF;TG)  omitted in original MINDy; thus, hypotheses for modulator discovery 
became less constrained. This means that null co-information distribution can be directly built by 




Figure 3-1 General third party regulatory topologies depending on modulator roles on TF. 
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MINDy and coMINDy algorithms have utilized the level of gene expression in a GEP as 
a proxy of the protein activity of the corresponding gene in order to identify gene-specific three-
way interactions. However, in biological reality, it is known that signaling molecules have both 
in TF-dependent and TF-independent functions (Fu et al.; Lee et al.; Day and Tuite; Chen and 
Rajewsky; Filipowicz, Bhattacharyya and Sonenberg; Linding et al.; Bader, Betel and Hogue). 
Thus, global modulators need to be considered. In order to do so, we propose a novel framework 
to identify global modulators from the pools of transcriptional interactions and three-way 
interactions, identified by (h)ARACNe and (co)MINDy, respectively. Based on this analysis, 
inferred modulators can also determine whether the modulator protein will regulate TF-target 
interactions with and without considering the mode of modulator action. To compare the overall 





3.2 Materials and Methods 
The signalome was defined as the compendium of signaling proteins (SP) annotated as 
protein kinases, phosphatases or cell surface receptors in the Gene Ontology (GO) (Ashburner et 
al.). The term "transfactome" (Foat, Tepper and Bussemaker) is defined as the compendium of 
proteins annotated as transcription factors (TF) in the GO. Only proteins expressed in a set of 
254 GEPs from normal and tumor-related human B cells were considered in the analysis. This 
study had 12600 probe IDs which mapped onto 8957 unique Entrez ID genes in HG-U95Av2 
GeneChip platforms, (Katia Basso et al.; K. Basso, M. Saito, et al.; Lefebvre et al.; Kartik M. 
Mani et al.; Margolin, Nemenman, et al.; Kai Wang et al.). A total of 2674 SPs and 848 TFs 
were selected for signalomes and transfactomes, respectively. 
 
 




Figure 3-2. Procedure for computing  and identifying modulator (by courtesy of Dr. Wang) 
 
3.2.1 Why co-information? 
Based on the information theory and graphical inference model, we can derive the other 
third party interaction model as shown in Figure 3-1. Because three-way interactions are not due 
to direct regulation, the metric of MINDy was initially derived from the entropy difference 
between general third party topology and topology (a). However, this metric might include direct 
regulation as shown in Figure 3-1 (case b) where modulator and TF were supposed to form an 
active complex and directly regulate TG. Thus, using Equation 3-1, 3-2, and 3-3, we derived the 




⇔Hb(TF,TG,M ) = H (TF,M )+H (TF,TG)−H (TF)
     Equation 3-4 
and their potential entropy difference results from their different topologies as 
Δ = Hb(TF,TG,M )−H (TF,TG,M )
  = H (TF,M )+H (TF,TG)−H (TG)−H (TF,TG,M )
  = I(TF;TG |M )− I(TF;TG)+ I(TG;M )
  ≡ I(TG;M |TG)
.    Equation 3-5 
42 
 
Table 3-2. Functionally categorized regulators. # indicates the number of genes selected in each 
category. MF: molecular function; BP: biological process; CC: cellular component  
 
 
When M and TF form an active cofactor and it regulates its target gene, the topological entropy 
difference might become Δ = I(TG;P1 | P2 )  and P1  and P2  might be communicative.  
Before discussing coMINDy in more detail, we have to first examine the MINDy 
algorithm. In the MINDy algorithm, a much more computationally efficient procedure was 
derived under the simplifying assumption that TF and M are statistically independent. That is, 
the expression of a post-translational modulator of a TF should be statistically independent of  
expression of the TF. However, well-known graphical models showed that because we knew the 
direction of modification of TG by its regulators, the three way network topology probability 
function should be modified from Equation 3-1 to p(TF,TG,M ) = p(TF)p(M )p(TG |TF,M ) . 
Thus, its entropy difference becomes Δ = H (TF)+H (M )−H (TF,M ) = I(TF;M ) . In fact, 
because of I(TF;M ) = I(TF;TG;M )+ I(TF;M |TG)  and the assumption of 
I(TF;M |TG) ≈ const , we derive Δ ≈ I(TF;M;TG)  for the topology (a) in Figure 3-1. 
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Therefore, co-information is a more reasonable metric than I(TF;TG |M )  which was a core 
metric proposed by MINDy but is now proven to be a more appropriate metric for the topology 
(b) in Figure 3-1.  Even though I(TG;M |TF)  was the metric of the topology (b), we can use co-
information as its metric when assuming I(TG;M ) ≈ const  because  
 I(TF;TG;M ) =
I(TF;TG |M )− I(TF;TG)







     Equation 3-6 
Thus, we conclude that co-information is an extended and rational metric from cMI in the 
MINDy algorithm.  
3.2.2 Global modulators 
In MINDy, three-way interactions are inferred in a gene-by-gene fashion and only 
modulators which belong to MoMA are identified. Furthermore, inferred triplets are highly 
dependent on the pairwise interaction between a TF and its target gene (Kai Wang et al.). To 
overcome these limitations and identify a global testing metric, ‘co-information’ rather than  
was proposed in my research. The coMINDy algorithm, therefore, tries to mine different 
information spots as shown in the information diagram in Figure 3-3. However, newly inferred 




Figure 3-3 Information diagram 
 
However, post-translational activities of signaling molecules are believed to work 
globally, not in a gene-specific manner (Bader, Betel and Hogue). For example, this means that 
when a modulator, forms a protein complex with a TF and modifies the interaction between a TF 
and its target genes at a post-translational level, this modulator might globally influence all target 
genes of the TF. To identify whether or not an inferred modulator acts globally, we apply a post-
processing step where both transcriptional interactions inferred by hARACNe (or ARACNe) and 
modulator interactions identified by coMINDy (or MINDy) are utilized. Depending on the role 
of modulators in the biology of the cell, we might categorize inferred modulators as gene-
specific, TF-specific, and global.  
Gene-specific modulators (sM): The (co)MINDy algorithm infers a large number of genome-
wide three-way interactions TF-M-TG in both the transfactome and signalome in a gene-specific 
manner. Because the inferred interactions were tested by given metrics using GEPs, inferred 
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modulators play a three-way regulatory role at the transcript level. Here, genes are assumed to be 
specifically regulated by identified TFs and Ms. 
TF-specific modulators (TFsM): To check the modulatory effect of a TF on its target genes, 
inferred transcriptional interactions are firstly concerned in this research. As an intermediate-post 
processing step, TF-M pairs are selected from inferred triplets, but the direct targets of a given 
TF are selected by transcriptional networks inferred by (h)ARACNe. Remodeled sets of triplets, 
where one set with a specific TF-M pair is attached with inferred transcriptional target genes of 
given TF, are tested by a random shuffling method which builds the null distribution. We then 
choose significant triplets in the set; thus, we rebuild genome-wide three-way interactions in a 
less stringent manner. It is agreeable that gene-specific modulators are likely to  act at a 
transcriptional level, whereas this TF-specific modulator selection approach might partially 
cover both transcriptional and post-transcriptional domains simultaneously. 
Global modulators (gM): Post-translational modulators are believed to work globally; thus a 
global modulator should regulate all target genes of a specific TF. Because we do not have a gold 
standard list of target genes of any given TF, there is no way to identify the real modulators 
biologically. For simplicity, modulator candidates in the signalome were filtered when it had 
manually-driven insignificant modulatory interactions; that is, TF-M pairs which had more than 
15 target genes were assumed to be global (Lefebvre et al.). However, this approach did not 
consider transcriptional activities of given triplets and was very heuristic. To cover 
transcriptional activities in inferred TF-M interactions, all target genes identified by (h)ARACNe  
were used, similar to TFsM. Remodeled sets of triplets were tested with a random shuffling 
method and we then checked whether the TF-M pair forms global interactions. Thus, unlike 
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gene- and TF-specific modulators, global modulators might fully cover the post-translational 
domain at the transcriptional level.  
We built the selection scheme for global modulators as follows:   
1) The transcriptional interactions were reconstructed by original ARACNe; furthermore, 
the computationally refined interactions were refined by hARACNe. In addition, third 
party interactions were distinctively identified by MINDy and coMINDy in order to 
compare the inferring performances.  
2) From the TF-M pairs in (co)MINDy, all N target genes of the given TF, which were also 
identified by (h)ARACNe, were added in a given TF-M pair.  
3) We computed the metric values of rebuilt N triplets (TF-M-TGs) using either delta 
mutual information (dMI) in MINDy or co-information in coMINDy. In each element in 
N triplets, given modulator gene expression was randomly shuffled and its corresponding 
null distribution was built with the computed values given a corresponding metric.   
4) After hypothesis testing per each triplet, a) all significant triplets are selected as TF-
specific modulator interactions, and b) if the ratio of the total number of significant 
triplets is more than a given ad-hoc threshold ratio, we decide to define M as a global 











3.3  Results 
3.3.1 Gene-specific triplets from MINDy and coMINDy  
Gene expression profiling has been widely used in different aspects of research, including 
identification of gene signatures, discovery of drug targets, and identifying biomarkers (Butte et 
al.). Most network algorithms have used GEPs as the training input data with the assumption that 
mRNA expression level of a gene could be used as a proxy for its protein activity. Based on this 
assumption, the MINDy algorithm elucidates transcriptional as well as post-translational 
modulation events, where a TF and its target genes appear to only have an interaction in the 
presence of a third party gene: the so called modulator (M). These three-way interactions were 
split into two distinct pairwise interactions: Protein(P)-DNA(D) interactions between the TF and 
its target genes and  TF-modulator interactions that could be either P-TF or a TF-TF interaction, 
depending on whether the candidate modulator is a TF. As its testing metric, delta mutual 
information approximately computed the value of conditional mutual information I(TF;TG |M ) . 
With a high level of dependence on the given I(TF;TG) , the total numbers of inferred triplets at 
the probe ID level were 350638 and 623367 in the transfactome and signalome respectively.  
coMINDy computed co-information among all possible triplets and predicted 305639 and 
468624 triplets as three-way interactions in the transcriptome and signalome respectively. Using 
coMINDy these probe IDs were mapped to Entrez IDs, and corresponded to, 252886 and 362754 
triplets in the transfactome and signalome respectively whereas MINDy inferred 342311 and 
579248 triplets. As expected, the overlap between MINDy and coMINDy was only 1271 and 
1526 triplets at an Entrez ID level because of their mutually exclusive information mining as 
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shown in Figure 3-3. In addition, , the differential distribution of transcriptional interactions 
within inferred triplets were (Figure 3-5). 
To effectively benchmark the accuracy of MINDy and coMINDy inferences, a set of gold 
standard signaling protein (SP) and transcription factor (TF) interactions in human B cells would 
be required. Compiling such a reference set is difficult because: (a) experimentally validated 
protein-protein interactions in databases are still very sparse, especially for transient interactions 
(e.g., kinase-substrate); (b) inferred modulators can be either direct (i.e.. a physical SP-TF 
interaction), or pathway-mediated (i.e., SP upstream of the TF in a signaling pathway). Whereas 
the former could be represented in existing databases, the latter are poorly characterized; and (c) 
although inferred SP-TF interactions are highly human B cell context specific, human protein-
protein interactions have been validated in very heterogeneous or even artificial cellular contexts. 
To address (a) and (b) we benchmarked MINDy and coMINDy with datasets the protein-protein 





































Figure 3-5. Comparison of distributions of Spearman’s correlation between TF and TG within 
gene-specific three way interactions inferred by coMINDy and MINDy  
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We collected all known human PPIs from high-quality public databases including HPRD 
(Peri et al.), BIND (Bader, Betel and Hogue), DIP (Xenarios, Fernandez, et al.; Xenarios, Rice, 
et al.; Xenarios, Salwinski, et al.) and IntAct (Hermjakob et al.; Aranda et al.). These have been 
experimentally assessed, either in single biochemical assays, or by high throughput techniques 
such as Y2H. These datasets cover 426 signaling proteins and 341 transcription factors. We also 
included kinase-substrate interactions inferred by the experimentally-validated algorithm 
NetworKIN (Linding et al.). This algorithm utilized information from consensus motifs in kinase 
catalytic sites and substrate phosphorylation sites assessed by Mass Spectrometry, as well as 
cellular context and curated pathways. Such information is completely orthogonal to that of gene 
expression profiles. Therefore, enrichment of their common predictions can be used to assess 
inferred modulator’s validity, as false positives from the two methods should not be correlated if 
either of them makes random predictions. Due to the limited number of kinase families for which 
consensus motifs are known, NeworKIN covers only 389 SPs and 223 TFs. The PPIDB (list of 
protein-protein interactions in public databases) and KSIDB (list of kinase-substrate interactions 
predicted by the NetworKIN algorithm) interactions, used for in silico validation of MINDy and 
coMINDy predicted signalome-transfactome interactions, can be found on the website at: 
http://wiki.c2b2.columbia.edu/califanolab/PSB2009/.  
As shown in Figure 3-6, the overlap in number of TF-M pairs  generated from gene-
specific triplets between MINDy and coMINDy was 86204. Also, the identified number of TF-M 
pairs which were validated by PPIDB in silico were 715 and 550 in MINDy and coMINDY 
respectively, with 260 and 222 TF-M overlapping pairs with KSIDB. Table 3-3 and Figure 3-6 




Table 3-3. Summary of predictions made by MINDy, coMINDy, PPIDB, and KSIDB 
 
3.3.2 Gene-specific modulator expression was not a good proxy to its protein activity. 
Despite the fact that mRNA expression levels  could be used as a proxy for protein activity, it 
was not a reliable assumption for identifying post-transcriptional or post-translational regulation. 
In fact, a wide range of post-transcriptional regulations have been observed in eukaryotes, 
including splicing control, mRNA transcript stability, localization and translation (Day and 
Tuite). Furthermore, RNA-binding proteins (Blencowe et al.) are known to be key players in 
post-translational regulation. Thus, we hypothesized that if a modulator experienced post-
translational regulation, the activity of the modulator should globally control the transcription 
factor activities.   
TF-M pairs were selected from the list of three-way interactions predicted by MINDy and 
coMINDy. 465849 TF-M pairs generated in MINDy and 271688 TF-M pairs generated in 
coMINDy were selected to process the global modulator selection. When a TF has a regulon (a 
group of target genes) predicted from ARACNe or hARACNe, we hypothesized that if a 
modulator functions globally, then transcriptional interactions for given TF and its regulon 
should be altered by a given modulator. After 1000 times of randomly shuffle sampling with M, 
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each TF-M-TG triplet built the null distribution with the testing metric of MINDy or coMINDy. 
The global modulator was then selected by the majority voting method. Thus, the tested 
modulator was highly dependent on the TF  interaction with its target genes; that is, the inference 
algorithm affected the global modulator selection procedure and generated slightly different 
global modulator sets when hARACNe and ARACNe regulons were distinctively used. Here, we 
only compared the results of global modulator based on h3ARACNe and ARACNe applying 
MINDy and coMINDy algorithms separately.  
The inferred global modulators from coMINDy + h3ARACNe (coM_h3A), coMINDy + 
ARACNe (coM_A), MINDy + h3ARACNe (M_h3A), and MINDy + ARACNe (M_A) were 
comparatively validated with PPIDB and KSIDB. The number of TF-gM pairs inferred by 
MINDy + ARACNe and coMINDy + h3ARACNe predicted in silico by KSIDB were 4 and 12, 
respectively. Similarly, using PPIDB to compare prediction performance of M_A and coM_h3A, 
7 PPIs and 16 PPIs were validated. 
 
Figure 3-6. Comparison between MINDy and coMINDy and its in silico validations with PPIDB 




Figure 3-7 Overall comparisons showed that there were no huge differences in TF-gM pairs 
caused by ARACNe and hARACNe networks, whereas almost no TF-gM overlaps between 
coMINDy+h3ARACNe and MINDy+ARACNe.   
 
 As expected and shown in Figure 3-7, because of slight difference between h3ARACNe 
and ARACNe, the overlap between global modulator lists of coM_A and coM_h3A (and M_A 
and M_h3A) were significant. However, because of the different information mining spots in 
each case, there were very small TF-gM overlaps between coM_h3A and M_A.  
Table 3-4. Comparison with overlap between inferred global TF-M pairs and PPIDB or KSIDB 





MINDy infers modulation of transcription factors and their targets based on the 
differential (delta) mutual information between transcription factor and target in  conditions 
when the modulator is high and low (top 35% M+ and bottom 35% M-). Since mutual 
information is a non-negative measure, however, delta mutual information (dMI) does not 
differentiate between the negative and positive modes of modulation; furthermore, even though 
TF-TG has high mutual information in both M− and M+, modulators might not be identified due 
to low dMI. Thus, the modes of modulator action were limited to detect general modulation 
scenarios. However, in coMINDy the interaction information has its corresponding positive or 
negative sign and might be able to differentiate MoMAs. Not only linearity of MoMAs but also 
nonlinearity modulation scenarios might be detected by coMINDy. Therefore, due to the mining 
of different spots in the information diagram, three-way interactions directly predicted by 
coMINDy are theoretically mutually exclusive with those identified by MINDy in both detection 
and classification capabilities. 
Both MINDy and coMINDy treat all SPs and TFs as candidate modulators, and we 
validated predicted global modulator and TF interactions using a very conservative approach: the 
most likely topology of the interface between SPs and TFs in human B cells, supported by 
significant physical evidence from both literature and novel biochemical assays, was obtained by 
mapping MINDy predictions onto known direct interactions in PPIDB and KSIDB. Using known 
protein interactors has the advantage of producing hypotheses about direct interactions that are 
immediately testable. Global modulators were inferred by examination of a combination of 
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transcriptional and post-translation networks. The results showed that the combination of 
coMINDy and hARACNe outperformed the others inferred either by the combination of MINDy 
and ARACNe or by the combination of MINDy and hARACNe. The combination of coMINDy 
and hARACNe was directly compared with MINDy and hARACNe.  However, due to the very 
limited evidence, it is somewhat impetuous to conclude that global modulators predicted by 
coMINDy are more likely to be true than those predicted by MINDy in human B cells. In 
Chapters 4 and 5, we will computationally validate and compare the performances of the 
regulatory network-based prediction for genome-wide effects(Chapter 4) due to perturbation and 
causes of phenotypes(Chapter 5), using coMINDy (gM) + hARACNe, and MINDy (gM) + 
ARACNe.  
The work described in this Chapter provides both computational and experimental 
evidence suggesting that the MINDy and coMINDy algorithm can be effectively used to map 
physical and pathway-mediated post-translational interactions between SPs and TFs, using large 
GEP datasets. Due to the lack of appropriate high-throughput studies, such as protein-chip 
profiles and ChIP-Chip/Seq assays, the dissection of post-translational interactions is lagging 
significantly behind that of their transcriptional counterparts. As a result, algorithms that are able 
to provide high-accuracy, cell-context specific hypotheses for biochemical validation may 
significantly improve our ability to elucidate post-translational processes and their effects on 
regulatory networks. For instance, in a recent study inferred modulators were highly enriched in 
experimentally validated interactions and silencing the most pleiotropic modulator, STK38, 
produced expression profiles that were highly consistent with the inferred STK38 modulon (K. 
Wang, M. J. Alvarez, et al.; Kai Wang et al.).  
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To test nonlinear modulators identified by coMINDy, it is necessary to supply the 
intermediary molecules to the system. This makes nonlinear modulators harder to test, especially 
in vitro. Also, dependency between M and TF activity on TG can be a result of non-causal 
relations — if any of the M, TF and TG genes were replaced with a highly correlated substitute, 
there would still be a non-linear dependency. However, a priori interactions were constructed, 
thus a substantial amount of nonlinearly dependent and non-causative cases were filtered out in 
MINDy.  
Important biological questions about signaling networks include; What are the signaling 
proteins that control a specific transcriptional program?;  what are the shortest paths through 
which a signaling protein may affect the activity of a TF?; and what signaling proteins are 
upstream or downstream of other signaling proteins? To address these questions, genome-wide 
computational analysis of the interface between signaling and transcriptional networks should be 
considered. Importantly, modulators of transcription factors should be considered as potential 
drug target candidates since they can specifically and delicately alter activity of the TF. 
Generalized modulation maps can help to infer this set and provide the direction of modulation 
for each target gene, allowing researchers to pick targets that are more likely to lead to desired 
outcome with the least  side effects.  The combination of these results and those from in vivo 
experiments may significantly improve our understanding of the role of cellular signaling in the 





Prediction of genome-wide consequences of perturbations using a 
network biology approach 
4.1 Introduction 
While our ability to dissect cell-context specific regulatory interactions in mammalian 
cells has greatly improved in recent years (K. Basso, A. A. Margolin, et al.; Stolovitzky and 
Califano; Lefebvre et al.; X. Yang et al.; Pe'er and Hacohen), there are no experimentally 
validated methods to use genome-wide regulatory models to predict how a cellular system will 
behave as a result of a targeted perturbation, such as ectopic gene expression or RNAi mediated 
silencing of a gene. Yet advances in this area would bring us one step closer to the elusive goal 
of accurately modeling complex mammalian biological systems in silico.Significant progress has 
been shown in two related areas, suggesting that the predictive nature of regulatory networks 
may be harnessed toward this goal. First, the activity of predicted targets of a specific 
transcription factor, following its ectopic expression or silencing, can now be reasonably well 
approximated, provided that target inference is context specific (Carro et al.; Lefebvre et al.). 
Conversely, identification of genes necessary and sufficient for the implementation of a specific 
cell-state transition signature, also known as master regulators or driver genes, has also been 
demonstrated (Carro et al.; Lefebvre et al.; Pe'er and Hacohen; Schadt et al.) . Yet, it is not clear 
how these approaches may be extended to predict genome-wide effects resulting from the 
experimental manipulation of individual regulator genes, such as TFs or protein kinases. 
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Indeed, the only experimentally validated approaches for quantitative prediction of 
mammalian cell behavior are based on detailed stoichiometric (Samaga et al.) or kinetic models 
(Neves et al.) that are critically dependent on the ability to precisely assess a vast and complex 
landscape of kinetic parameters, where small changes may result in divergent predictions. 
Because of the parameters optimization problem in their estimation, these models generally scale 
up only to relatively small regulatory networks consisting of a handful of genes, and have never 
been used to model genome-wide regulation. Although a few probabilistic methods have been 
proposed, they have not been experimentally validated. Thus our ability to model cellular 
responses is still in its infancy (Costa et al.; Gustafsson and Hornquist) . 
 Based on the ability to accurately model regulatory interactions in mammalian cells, 
including transcriptional and post-translational interactions using algorithms such as ARACNe 
(Margolin, Wang, Lim, et al.; Margolin, Nemenman, et al.; K. Basso, A. A. Margolin, et al.) and 
MINDy (K. Wang, M. Saito, et al.), we propose a Bayesian Statistics method to decouple the full 
regulatory model of the cell into a large number of smaller regulatory programs that are 
independent of each other, under the assumption that the time step over which perturbation 
effects are propagated is sufficiently small. By re-evaluating these programs at each time step 
using multivariate analysis and using them to evaluate gene expression changes only over the 
next time step, the proposed approach allows computation of the rearrangement of the full 
cellular expression landscape, until equilibrium or a limit cycle is reached. We should note that 
this approach integrates probabilistic relationships that are inferred from asynchronous cell 
populations, rather than from single cells. As a result, the model is only expected to be predictive 




 To allow model plasticity over time, a key element of our approach, we start from a 
multivariate regulatory network topology (i.e., a topology that explicitly represents both pairwise 
and three-gene interactions) determined by integrating context-specific transcriptional and post-
translational interactions and reconstructed using the (h)ARACNe and (co)MINDy algorithms. 
ARACNe, which infers direct transcriptional targets of every TF in the cell, has been 
experimentally validated in a variety of cellular contexts and for several TFs (Lefebvre et al.; 
Carro et al.; Zhao et al.; Palomero et al.; Margolin, Wang, Lim, et al.; Margolin, Nemenman, et 
al.; K. Basso, A. A. Margolin, et al.). MINDy, which has also been extensively validated 
(Lefebvre et al.; Zhao et al.; K. Wang, M. Saito, et al.; K. Wang, M. J. Alvarez, et al.; K. M. 
Mani et al.), identifies candidate modulators that can affect the ability of a TF to regulate its 
targets. MINDy-inferred interactions are the key contributors to the dynamic nature of the 
regulatory programs, which are re-evaluated at each time step. For instance, if MINDy predicts 
that high expression of a protein kinase increases the activity of a TF on its targets, this will be 
accounted for in the programs regulated by that TF as the kinase activity changes over time.  
We tested our method by predicting the effect of lentivirus mediated shRNA silencing of 
several regulator genes in human B cells, including both transcription factors (BHLHB2, 
MEF2B, FOXM1, and MYB) and signaling proteins (HDAC1 and STK38) and then comparing 
computational predictions and experimental assays. Analysis was performed in human Burkitt’s 
Lymphoma cell lines, whose experimentally validated regulatory networks can be inferred from 
a large collection data from normal and tumor-related mature human B cells (Lefebvre et al.; Kai 
Wang et al.; K. Basso, A. A. Margolin, et al.). Overall, this constitutes the first example of an 




4.2 Materials and Methods 
A ‘perturbation’ in a regulatory system results from an alteration of gene function, 
externally induced by small molecules such as drugs and toxins or internally manipulated by 
RNA interference (RNAi) (Bennett et al.). Here, a perturbation is assumed to be made internally 
at the level of transcription of a specific gene; Other sources of alterations such as environmental 
stimuli are excluded from our consideration because both their quantitative analysis and 
identifying their direct targets is almost unfeasible (Hohmann). The major aim of our study is to 
predict how a perturbed regulator systematically propagates the second order causal reactions 
into genome-wide regulatory networks at the transcript level. Therefore the gene selected and 
manipulated by shRNA should be known as a regulator of cellular systems: i.e., a transcription 
factor or a modulator.  
We functionally categorize our methods into three distinct parts: (A) Prediction 
Procedures, (B) Experimental Procedures, and (C) Performance Testing procedures. 
4.2.1 Prediction procedures 
The procedure for genome-wide prediction of mRNA expression carried out in this paper 
is composed of three steps: (1) Comprehensive transcriptional networks were inferred by 
hARACNe which were statistically strengthened by bootstrapping methods. In order to make 
transcriptional interactions more sophisticated and realistic, modulators are taken into 
consideration, which were discovered by using the coMINDy algorithm. (2) As a result of 
applying 1st order Markov Blanket (Judea  Pearl; Judea Pearl) to all genes in a GEP, each gene 
has its regulatory blanket. Several different criteria for reducing computational complexity were 
applied to the all interactions in given blankets. (3) Regulatory effects on a hub gene are 
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statistically or probabilistically trained with other genes in the blanket by proposed fitting 
models.  
4.2.1.1 Network inference    
ARACNe removed indirect interactions in Markov-chained three nodes by data 
processing inequality (DPI). Furthermore, hARACNe works in the extended number of Markov 
chained nodes by applying higher-order DPI (Han). Thus, we made inferred interactions more 
accurate by pruning hidden indirect interactions in the ARACNe results, as described in Chapter 
2. 
In order to unravel more complex but realistic regulatory networks, our laboratory has 
proposed a novel algorithm, called MINDy (Kai Wang et al.), which is able to find modulators 
which control TF-TG regulations. To overcome its intrinsic limitations such as mode of 
modulator action, coMINDy was proposed and successfully inferred the third party regulations. 
With transcriptional interactions and modulator interactions discovered by hARACNe and 
coMINDy, we built the selection criteria for a global modulator to reconstruct a gene regulatory 
network. For more details, refer to Chapter 2 and 3. 
4.2.1.2 System dynamics  
In order to reduce prediction complexity from inferred networks, we need to narrow our 
focus to the simplest inferential sub-network on a gene by applying K-Means clustering 
(Mitchell; Duda) for regression models and MI-priority selection for Bayesian models, 
respectively, to the regulatory blanket : Each Markov blanket narrows its original definition by 
considering only the nearest parental (1st order upstream) neighbors of a gene because any types 
of causation flow directionally from parents to their children. Furthermore, these transcriptional 
62 
 
Markov blankets are redefined by attaching global modulators to hub genes’ corresponding TFs. 
In addition, in order to emphasize more regulatory effects from the perturbed gene than others, 
we always included the node in each blanket which is indicated to be the perturbed gene in this 
pruning process; the so-called ‘ubiquitous’ regulator selection scheme. As a result, we decreased 
computing cost dramatically without crucially affecting the results.  
It is more understandable that each regulatory blanket forms a node of predictive system 
dynamics which build a Trellis-like diagram. It conceptually shows how drastically complicated 
regulatory mechanisms are coupled, and how the perturbation effects are systematically 
propagated within them. Furthermore, these iterative prediction steps of a trellis diagram show 
how causal effects of regulation are propagated over time. 
4.2.1.3 Mathematical models per regulatory blanket 
In statistics, multiple, functional, or logistic regression models have been extensively 
used to fit pathogenic or pathologic data to a model deterministically (Gregoretti et al.; Kim, Lee 
and Park; Segal, Dahlquist and Conklin). With marked contrast, data are considered 
probabilistically as the representations of random variables which are composed of a system. 
Multiple linear regression models are vulnerable to outliers but computationally cheap; while 
Bayesian models are resilient to overfitting problems but suffer from the curse of dimensionality 
(i.e., size of samples) and quite extensive computing cost. Although there are uncovered 
limitations to model a system properly, we would favor either regression or Bayesian models 
rather than kinetic models (Bickel et al.; Sayyed-Ahmad, Tuncay and Ortoleva; Yugi et al.) 





Figure 4-1. To explain the preparation for predictive system, we here use toy examples: (a) 
transcriptional network by (h)ARACNe and one example of transcriptional Markov Blanket, (b) 
regulatory network by (h)ARACNe and (co)MINDy and one example of regulatory Markov 
Blanket, and (c) Trellis-like diagram to show how each iterative step for prediction works 
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In additive models, a simple multiplicative approach was used to combine the effect of 
TFs and modulators; thus, the mathematical model became additive because of the log-
transformation of data. The mathematical formulation per blanket of the additive model is as 
follows: 











∑ ,       Equation 4-1 
where G[ ]  is the numerical value of expression of gene G, γ  is the interceptor for linear 
regression, K  is the total number of TFs in the given blanket,   kα ’s are considered how amount 
of transcriptional effect by corresponding TF, J  is the total number of modulators in the given 
TF, 
ik
β ’s are conceptually regarded as the amount of modulatory effect by the corresponding 
modulator, and 
ik
M ’s are the ith modulator between kTF  and TG. The least square method is 
applied for training parameters ( kα  and ikβ ) of each blanket with GEP training data .  
Based upon the least square error criterion of multiple linear regression, unknown 
coefficients of every blanket are estimated with the training data: γ̂ , kα̂ , and jkβ̂ . The 
expression levels at iteration time t of all hub genes are simultaneously updated with the previous 
iteration time point by the unit of their regulatory blanket as follows;  
TG[ ]t = γ̂ + TF[ ]k
t−1












∑                 Equation 4-1(a) 
where t = 1,2,3,… when 1=t , [G]0  is the initial condition of G .  
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In order to overcome disadvantages such as overfitting and underfitting caused by 
outliers in regression models, each node in a regulatory blanket is regarded as a random variable. 
However, due to the curse of dimensionality with respect to the sample size, 2- or 3-dimensional 
joint and conditional probability density functions (PDF) are so restrictively precisely estimated 
by multivariate kernel density estimation (KDE) that we can functionally combine them in order 
to restore a multidimensional PDF of a hub gene in a blanket. Thus, we propose the Bayesian 
model as an efficient way to selectively hop among all repositories of partial conditional PDFs to 
restore a full conditional probability density function (cPDF). 
Using Bayesian graphical models in each blanket which has a full cPDF, 
 k k kk i iMTFTGp ∀ ∀ ]),[|( , we make a repertoire using so-called blanket motifs: )|( nTFTGp  
and ),|(
imm
MTFTGp . In a hopping repository, the expectation of conditional probability 
density functions (cPDFs) is regarded as the most probable predicted expression of a hub gene 
(i.e., TG). This process spatially takes place in every blanket and temporally does along iterative	 
steps as follows: 
























	       Equation 4-2 
where t][Φ  is the expression level of a gene Φ  at an iterative prediction time t , TG  is a hub 
gene of each regulatory blanket, { }kTF is the total set of transcription factors  in the blanket of 
TG , and { }kM  is the total set of modulators which correspond to a given kTF  in the blanket.  
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Based on the hopping method, which splits the blanket into regulatory motifs composed 
of distinct triplets ),,(
ikk
MTFTG these triplets are jointly considered as random variables. 
K  and Ik are the total number of considered motifs and their corresponding three-way 
interactions captured by the hopping scheme, respectively.  
Therefore, to predict the expression level of a hub gene every blanket is simultaneously 
























κκκκ .         Equation 4-2(a) 
 
 




4.2.2 Experimentally validated data 
4.2.2.1 Gene expression profile dataset 
To consider genome wide dynamics of activity of genes in B cell, 254 GEPs from 
normal and tumor phenotypic B cells were chosen (available from GEO - series GSE2350, 
including samples GSM44075-44095, GSM44113-44302 and GSM65674-65716). These profiles 
were generated with the Affymetrix HG-U95Av2 GeneChip which has over 12,600 probe-sets.  
4.2.2.2 Biochemical perturbation assays 
One protein kinase (STK38), four transcription factors (BHLHB2, MEF2B, FOXM1, 
and MYB), and a deacetylating enzyme (HDAC1) were selected as targets to be perturbed by 
shRNA-mediated knock-down. 
Human embryonic kidney 293T cells were maintained in DMEM supplemented with 
10% FBS and antibiotics. The Burkitt’s lymphoma cell lines, P3HR1, ST486, and ODH-III were 
maintained in IMDM supplemented with 10% FBS and antibiotics. 
Lentiviral vectors for BHLHB2 shRNA (TRCN0000013249), MEF2B shRNA 
(TRCN0000015739), HDAC1 shRNA (TRCN0000004818), STK38 shRNA 20 
(TRCN0000010216), FOXM1 shRNA (TRCN0000015546), MYB shRNA (TRCN0000040062)  
and Non-Target control shRNA (SHC002) were purchased from Sigma-Aldrich (St. Louis, MO). 
Lentiviral supernatants were produced by transiently co-transfecting the lentiviral vectors, the 
packaging vector Δ8.9, and the VSV-G envelope glycoprotein vector as previously described 
(Lois et al., 2002; Naldini et al., 1996). For transduction, ODH-III, P3HR1 and ST486 cells (2 x 
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106 cells/ml) were mixed with viral supernatants, supplemented with 8 µg/ml polybrene and 
centrifuged for 120 min at 450g. The ODH-III and ST486 cells were collected for analysis 96h 
and 60h post-transduction, respectively. The lentivirally transduced P3HR1 cells were selected 
with puromycin (0.5 µg/ml) for five days and collected for analysis. 
For each regulator of interest, five samples transduced with the regulator-specific 
shRNA and five with non-target control shRNA were obtained for BHLHB2 and STK38 
shRNAs while four with non-target control shRNA were obtained for HDAC1 and MEF2B 
shRNAs. Total RNA was extracted with Trizol reagent (Invitrogen) and purified using the 
RNeasy kit (Qiagen). Biotinylated cRNA was produced according to the manufacturer’s 
instructions, starting with 6µg of total RNA and following the one-cycle cDNA synthesis 
protocol (Affymetrix, 701025 Rev.6). 15 µg of fragmented cRNA was hybridized to HG-
U95Av2 microarrays (Affymetrix) and gene-expression values were determined using the 
MAS5.0 normalization method provided in the Affymetrix GeneChip Operating Software 
(GCOS). For analysis of the causal effects of perturbation, expression levels within each 
experimental set, in both perturbed and control samples, were averaged. 
4.2.3 Performance testing  
The effects of a perturbation are thought to result in the arrival of a cell at  steady state 
after a certain time, and this should occur after a number of iterative steps. The activities of all 
genes activities at each iteration are predicted and updated by proposed blanket-based fitting 
models. Expression levels of each gene propagate from one iterative time step to the next 
throughout the network. If a model is able to explain the real regulatory system, its results should 
converge systematically. This concept can also be used to check whether or not each proposed 
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fitting model is valid. As a result, we observed that prediction results of each model converged to 
a limited extent with their real regulatory scenarios. 
Using a simple convergence test, L = lim
n→∞
Ψn+1 Ψn , when the predicted value after 
many iterations lies on the open set of ),( σσ ∂+∂− LL , we declare it to be convergent; if it fails 
the test the result is described as oscillated or divergent. Here we set the σ∂  automatically 
within 10% of the standard deviation of a gene’s predicted expression in GEP. 
In order to check whether or not predicted performance is achieved at random, we used 
100 random networks. In this approach the network topology of an inferred regulatory network 
by hARACNe and coMINDy is preserved but only the node for the directly perturbed gene is 
fixed in the topology, whereas the nodes for all other genes are randomly shuffled. When the 
same amount of perturbation is applied to given perturbed regulator, the propagation of causal 
effect of perturbation should flow differently in each random network.  
The initial expression condition of each gene was taken as the average across the 
training dataset with the exception of the perturbed gene. In the testing data composed of control 
and shRNA-treated microarray data, average levels of a perturbed gene in control samples and 
treated samples were initially applied to the prediction step and were then fixed through all 
iterative steps. Also, from the systematical viewpoint, both control and treatment were 
simultaneously predicted with the same initial conditions with the exception of the perturbed 
regulator; otherwise, it suffered from the problem of prediction bias, which means that if a 
prediction was simulated for treatment, then a similar predictive simulation should be applied to 





Figure 4-3. ix  is the averaged experimental expressed level of treatment or control samples of 
the i-th gene, P  is the number of order in GEP where perturbation occurs, T  is the given 
training data, irealΔ  is a real differential expression between real treatment and real control of the 
ix , ipredictΔ  is a predicted differential expression between predicted treatment and control of the 
ix̂ , and )( ixf  is the predicted N-tuple expression vector for all genes with given ix . 
 
A common problem in genomic data mining is the identification of sets of genes 
associated with a given condition. Despite its validity, a gene-centric differential expression 
analysis uses only the most significantly altered portion of a list of all genes, and consequently 
loses its statistical power to detect gene sets enriched in moderately affected genes. Also, 
differential expression analysis does not take the group of the genes into account which leads to 
loss of information, particularly when the list of genes is long. Recently, gene set enrichment 
analysis (GSEA) (Aravind Subramanian et al.) has been proposed as a better alternative to cover 
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drawbacks of gene-centric analysis such that it finds the statistical significance of a given gene 
set. However, there is a drawback in GSEA when computing the normalized enrichment score 
(NES) because resolution of nominal p-value and NES in GSEA are highly affected by the 
number of permutations for making a null distribution of enrichment score (ES). Recently, our 
laboratory has implemented the parametric weighted enrichment analysis (PWEA) (Kim and 
Volsky; Alvarez) so that we can dramatically reduce the time to compute NES.  
For pre-ranked tests in PWEA, the reference statistics use absolute values of predicted 
differential expressions in each real and random network because we need to consider both 
upregulated and downregulated sets of genes simultaneously. Moreover, the gene set is selected 
by applying a t-test with control and treatment samples in the experimental perturbation dataset. 
Another option is to build a reference set from experimental data and select a gene set is from 
prediction data. However, it is hard to select significant gene sets from predicted differential 
expression because they are relative values. However, when a gene set is made from 
experimental data  it means that chosen gene set is statistically significant. It follows that the 
same gene set is applicable to PWEA with different reference statistics from all networks, and 
the results of PWEA with all networks are mutually comparable without any bias.  
As we mentioned earlier, we designed the double hypothesis testing approach to ensure 
the most accurate prediction performance. This uses p-value or NES from PWEA and random 
networks. Even though PWEA generates a nominal p-value from computed NES, we need to 
ensure that the NES from the real network does not occur due to random effects. Thus, another 
hypothesis testing is carried out with the null distribution built with all NES values from random 
networks. Application of the Z-test can then be used to show its statistical significance by p-









4.3.1 Perturbation dataset analysis 
We predicted the behavior of a Burkitt’s cell lines following lentivirus mediated shRNA 
silencing of several genes, including four TFs (MYB, FOXM1, MEF2B and BHLHB2) and two 
signaling proteins (HDAC1 and STK38) to determine whether the model could address both 
transcriptional and post-translational effects. Results were compared to the corresponding 
experimental silencing data, which were performed in three Burkitt’s cell lines. Quality of the 
prediction was determined by performing GSEA of the statistically significant differentially 
expressed gene set, using all genes ranked from to most underexpressed to the most 
overexpressed following the in silico simulation. We used a variable threshold of statistical 
significance to determine whether the enrichment was consistent across a broad range of 
significance values, indicating that the method is robust. Specifically, one would expect that for 
very stringent p-values, too few genes would be selected as significantly differentially expressed 
which would not allow sufficient statistical power to determine the GSEA enrichment. Both the 
regression model and the Bayesian model were tested. 
4.3.2 Analysis of prediction performance 
To simulate an initial resting point corresponding to the cell context in which the 
perturbation was performed, we used an initial vector of GEP values  at 
the initial iterative step which was equal to the GEP of the corresponding control cell line. Gene 
knockdowns were simulated with the control and treated value of the corresponding gene’s 
expression levels.   
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Figure 4-5. Red bars are averaged expression levels in each control dataset, whereas blue 
bars are the averaged case (shRNA treated) expression levels. 






































Figure 4-6. Based on the cutoff p-value of T-test between control and case samples, we show 
how many genes are involved in the corresponding tested gene set. 
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The predictive performances were tested twice in order to avoid random effects of GSEA. 
Firstly, when GSEA was applied, gene sets were determined by cutoff p-values from a two sided 
t-test using control and shRNA treated microarray data. Cutoff p-value thresholds were set from 
0.001 to 0.1 with increments of 0.01. Sequentially, with the null performance distribution with 
100 random networks, the performance of the original network was tested using a Z-test.  These 
cascading performance tests were designed to avoid random performance improvements by 
GSEA.  
For genome-wide prediction of the causal effects of perturbation, we compared the 
results of two predictive approaches: (a) a regression model and (b) a Bayesian model using gene 
regulatory networks inferred by hARACNe and co-MINDy. In addition, to select biological as 
well as systematically consistent modulator interactions from hARACNe and co-MINDy, we 
considered the global modulator selection scheme. In order to reduce computational complexity 
but not to seriously affect the predictive performance, we selectively utilized the  regulatory units 
of hub genes in each Markov blanket. We applied K-Means clustering in regression models, 
whereas higher co-information selection was used in Bayesian models. For more details, see 
Materials and Methods in Chapter 4. 
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MEF2B : Bayesian vs. Regression














































HDAC1 : Bayesian vs. Regression








































STK38 : Bayesian vs. Regression










































FOXM1 : Bayesian vs. Regression















































MYB : Bayesian vs. Regression




































Figure 4-7. Predictive performance comparison: Bayesian vs. Regression model with six 
perturbation cases. We also compare the predictive performance with hARACNe+coMINDy vs. 
ARACNe+MINDy. Perturbed genes targeted by shRNA were BHLHB2(1), MEF2B(1), HDAC1(2), 
STK38(2), FOXM1(1), and MYB(1), where (1) is for TF and (2) is for modulator. Bayesian model 
outperformed regression model which also suffered from divergence problem. 
As shown in Figure 4-7, our  methods were highly predictive when validating all cases of 
six perturbation datasets, where four of perturbation targets are known as TFs and two of those 
are identified  as modulators by co-MINDy. Due to the effects of outliers, overfitting and more 
importantly the divergence problem after many (~200) iterations, the less selected regulator units 
there were, the better performance the regression model had. However, the Bayesian model had 
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the major advantage that it was not highly affected by outliers or overfitting problems. It was 
also resilient to noise and ensured convergence with much smaller (<20) iterations. This 
Bayesian model performed much better in both TF-perturbed and M-perturbed datasets than the 
regression model. 
For computationally validating improvements by hARACNe from ARACNe and 
coMINDy from MINDy, two different approaches were taken. First, using only transcriptional 
networks inferred by ARACNe and h3ARACNe, we applied our predictive simulation with the 
same perturbation datasets. However, because HDAC1 and STK38 only worked as modulators, 
the other perturbation datasets for TFs were used to check the predictive performances. Figure 
4-8 showed that when either BHLHB2, MEF2B, or MYB was perturbed, the predictive 
performances applied with h3ARACNe outperformed those with ARACNe, whereas in the 
FOXM1 perturbation simulation ARACNe performed slightly better. In addition, with the same 
transcriptional interaction inferred by h3ARACNe, the perturbation simulation with global 
modulators processed by coMINDy produced a much better predictive performance than MINDy 
as shown in Figure 4-9.  
To check the random effect of the orders of reference lists in GSEA/PWEA, we plotted 
the enrichment score for real inferred networks and other random networks. In each plot, we 
found that the effects observed in simulated perturbations effects highly predictive and the 
proposed predictive system effectively captured up- and down-regulated genes genome wide. 

























































































Figure 4-8. Computational validation part1. Predictive performance comparison between 
ARACNe and h3ARACNe with Bayesian model  
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Figure 4-9. Computational validation part2. Predictive performance comparison between 






Pharmacologic studies  have entered a new era  in which therapies are directed towards 
protein targets specifically altered in genetic diseases such as cancer (Bender et al.; di Bernardo 
et al. "Chemogenomic Profiling on a Genomewide Scale Using Reverse-Engineered Gene 
Networks"; Iskar et al.; Nelander et al.; Xiong et al.; Zhu, Zhang and Schadt). With a lack of 
insight into  complex cellular processes, the direct identification of a suitable  target gene (TG) 
for effective drug development may be unfeasible. Thus, the ultimate goal of perturbation 
research is to reveal how human diseases are connected with genes and to use this information to 
identify drugs  mechanism in order to improve treatments. The main purpose of perturbation 
studies described here is to uncover the identity of gene networks involved in the cause and 
effect mechanisms in disease. However, this remains a daunting task, and even the most talented 
researchers still have to rely on laborious genetic screens to identify new targets. We propose 
that our predictive studies may serve as a pre-screening process which might allow refinement of 
the laboratory-based screens. Gene signatures in which most researchers are interested might be 
predicted under perturbation hypotheses generated with something resembling a real cellular 
mechanism. For example, the connectivity MAP (Justin Lamb) data, generated and heavily 
analyzed to reveal drug mechanisms in mammalian cancer cells, are used to identify the cause of 
the corresponding variations and to explain the effects of perturbation.  
To infer genome wide gene-gene interactions at the transcript level in eukaryotes, many 
computational methods in reverse engineering have been proposed and applied (Bansal, 
Belcastro, et al.; Katia Basso et al.; di Bernardo et al. "Chemogenomic Profiling on a 
Genomewide Scale Using Reverse-Engineered Gene Networks"; Goutsias and Lee; Hache et al.; 
81 
 
He, Balling and Zeng; Margolin, Nemenman, et al.; Margolin, Wang, Lim, et al.; Mehra, Hu and 
Karypis; Soranzo, Bianconi and Altafini). Reverse engineering is the only approach that is 
known to systematically reproduce equivalent mapping of transcriptional interactions derived 
from gene expression profiles (GEPs). Additionally, the B cell interactome (BCI) has been 
developed as a network of protein-protein, protein-DNA and modulatory interactions (Lefebvre 
et al.). The network contains interactions in reported in public databases and also interactions 
predicted by a Bayesian evidence integration framework which integrates a variety of generic 
and context specific experimental clues about protein-protein and protein-DNA interactions  with 
inferences from different reverse engineering algorithms, such as GeneWays (Rzhetsky et al.) 
and ARACNe (Basso; Katia Basso et al.; Margolin, Nemenman, et al.). Such predicted 
transcriptional networks have been considered an important step in the discovery of normal and 
disease-related cellular processes in mammalian cells. Albeit imperfect an imperfect approach, it 
has already proven useful as a guide to reveal a transcriptional regulatory mechanisms in 
mammalian cells (Basso; Katia Basso et al.).  
Depending on the type of research study, genes activities are analyzed in either a time or 
a steady-state manner (Bansal, Belcastro, et al.). For example, in studies on gene sets, it is 
appropriate that datasets are examined over a  time-course and analyzed with proper 
computational methods like dynamic Bayesian networks (David and Wiggins; Li et al.; Zou and 
Conzen). On the other hand, some genes are assumed to contribute to overall phenotypes of the 
cells independent of time. Due to recent intense research activity, a large amount of DNA chip 
data has been generated and is curated in publically available databases that can be easily 
accessed. However, it is difficult to get consistent data from time-course microarray data, 
because it is almost impossible to pinpoint experimental processes among studies such as 
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different measuring times, dosing times, and platforms used (Thomas et al.; Y. Wang et al.; 
Zoppoli, Morganella and Ceccarelli; Zou and Conzen). However, it is relatively easy to gather 
data and build associated databases,  when we regard them as steady states. 
Due to advances in RNAi technology, many genetic perturbation experiments have been 
performed  and expression profiles obtained. However, since pathway-based analysis of 
expression profiles has been the dominant approach, very limited studies have examined 
transcriptional regulation and therefore the profiling data were  only partially interpreted. In 
addition, the data themselves were not easily reproducible; different signatures or biomarkers 
were observed from the same phenotype. Pathway-based perturbation analysis might suffer from 
issues including: the fact that knowing that a  specific mutations exists within a cell is not 
enough to explain downstream target activities, highly interconnected pathways make the 
problem more complex, and drug treated upstream targets might produce many negative off-
target effects to effects on genes or gene products which do not belong to this pathway. These 
effects may also cause terrible difficulties  in the development of therapeutic strategies.  To 
overcome these limitations, the activity of every gene should be taken into consideration and 
when a gene or gene product is involved in perturbation experiments its causal effect should be 
covered genome wide. However, there is no genome-wide validated perturbation study so far. 
So, in order to predict the effect of perturbations genome-wide we here propose regulatory 
network-based prediction. The reconstructed regulatory networks are  have genome-wide 
coverage and if these networks mimic real cellular mechanisms, then this regulatory network-
based prediction approach will enable us to explain how the effect of perturbations are 
propagated through given network genome-wide. 
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We have proposed a novel paradigm in the computational prediction of genome-wide 
analysis of gene-by-gene variations  across samples that can be studied simultaneously in gene 
regulatory network. As a result, we have predicted the genome-wide causal effects of 
perturbation of a single gene in human B cells in an iterative manner. The study introduces four 
key innovations as follows: (1) instead of the individual interaction layers of previous studies, we 
cover whole genetic activities in human B cells after perturbation of a specific regulator; (2) 
rather than analyzing the differential properties of individual genes (e.g., expression profiles or 
genotypic data), we identify subsets of most differentially expressed genes that are of significant 
statistical power. Our models genome-widely predict differential expressions after perturbation 
of a specific transcription factor or modulator. Biologically, this is quite plausible, since 
biochemical perturbations as well as a wide variety of external stimuli (temperature, pressure, 
etc) will manifest through gains or losses of regulatory capability; (3) we experimentally 
validated six distinct perturbations (knockdown) of such regulators by shRNA directed against 
BHLHB2, HDAC1, MEF2B, STK38, FOXM1 and MYB in B-cell lines. These genes play roles 
as transcription factors or modulators or both in a mixed regulatory network. In each case, we 
identify the most differentially expressed genes based on proposed fitting models; (4) finally, we 
doubly tested our prediction performance with GSEA/PWEA and Z-test with random networks 
which provides the statistical power of predictive precision with gene sets which have the most 
significant enrichment score. 
We introduced and experimentally validated a Bayesian method to simulate the 
propagation of genetic perturbations on integrated gene regulatory networks inferred by the 
hARACNe and coMINDy algorithms from human B cell data. To computationally validate how 
hARACNe and coMINDy improved the prediction performance, we also compared the 
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performance of ARACNe and MINDy with the same procedure. The given hypothesis was that 
the more sophisticated inferred network we have, the better the predictive performance we get if 
the prediction systems were properly designed. Even though there are many false positive and 
false negative interactions in the inferred network, the overall predictive performance of 
combining hARACNe and coMINDy outperformed that of combining ARACNe and MINDy.  
However, the activities of signaling proteins tend to be much less correlated and out of 
scope with mRNA expression. Thus, the models including such protein activities tend to produce 
less robust and lower performance than that of transcription-only regulatory networks.  However, 
there exist more attractive advantages that approaches based on pathway analysis do not take 
account of the role of the perturbed regulator whether it works as a TF or modulator; whereas 
transcriptional models which only utilize transcriptional regulatory networks inferred by 
hARACNe are incapable of being applied when a modulator is perturbed.  
Furthermore, as shown in the Figures, the regression model was not guaranteed to reach 
convergence. It highly depended on how many regulators in regulatory blankets were chosen to 
estimate the updated expression level caused by direct or indirect perturbation effects, whereas 
the Bayesian model was not affected by selecting regulators in each blanket and quickly 
converged. Even though there exists a trade-off in computing cost and performance, the 
Bayesian model showed that the perturbation effect was reached in much fewer iterative steps 
and did not highly depend on the number of regulators in the blanket. Also, the predictive 
performances were well preserved regardless of the regulator selection method. See the 






Causation prediction of genome-wide phenotypic variations 
5.1 Introduction 
Translational medical research aims to convert our understanding of biological 
mechanisms into effective ways of treating and preventing diseases. Clinical tests based on 
biomarkers have been applied for more than fifty years, but their potential applications for 
disease detection, patient stratification and drug discovery have expanded since the beginning of 
the 21st century. The discovery of biomarkers is based on the comparison of phenotypes or 
changes across control and case groups. At the molecular level, such differences can be reflected 
in the differential activity or concentrations of genes, proteins, metabolites, and signaling 
pathways. Thus, biomarker discovery typically relies on the idea that those molecular species (i.e. 
genes, proteins, etc.) that display the greatest changes across phenotypes may be potential 
biomarkers. More recently, the discovery of novel biomarkers using genome-scale and different 
types of 'omics' data has become a crucial goal in both academia and industry. 
Systems biology is an emerging field that uses both experimental and computational 
approaches to develop an understanding of drug action across multiple scales of complexity from 
the molecular and cellular levels to level of tissues and organisms. By integrating multi-faceted 
approaches, systems biology can provide functional understanding of drug actions in terms of  
therapeutic efficacy and potential drawbacks. This includes understanding how drugs act in 
different tissues and cell types, as well as the issues of multiple actions within a single cell type 
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due to the presence of multi-coupled interacting pathways. Identifying molecular pathways 
targeted by a compound (drug) and the specific compound-involved interactions (mode of 
action) have been dominant for the development of new drugs, and also for new clinical 
applications of  drugs that already exist (Terstappen and Reggiani; Terstappen et al.; di Bernardo 
et al. "Chemogenomic Profiling on a Genomewide Scale Using Reverse-Engineered Gene 
Networks"). Such studies have been important from a translational perspective because they have 
aided in the identification of new drug targets, predicted adverse events and have improved the 
safety and efficacy of existing drugs. These goals have become increasingly important in the 
current practice of bio-medicine as many therapeutic challenges deal with complex diseases such 
as cancer. 
Systems biology is naturally suited to capturing the complexity of drug activity in cells 
(Berger and Iyengar; Hopkins "Network Pharmacology: The Next Paradigm in Drug Discovery"; 
Hopkins "Network Pharmacology"; Kartik M. Mani et al.), and has been used to attempt predict 
drug mechanisms of action by gene expression profiles following drug treatment (Gardner et al.; 
Hu and Agarwal; Hughes et al.; J. Lamb; Lamb et al.; K. Yang et al.), by comparing side-effects 
(Campillos et al.), by text-mining of the literature (Li, Zhu and Chen), or by applying chemo-
informatic tools to search for similarities between small molecules (Keiser et al.). Also implicit 
in such understanding of drug action is the knowledge of how complex diseases originate in the 
context of the whole genome of a cell. One particularly valuable approach is the use of network 
analysis of cellular systems. In this research, we describe regulatory network-based approaches 
for a global understanding of master regulators which are believed to cause genome-wide 
differential expression patterns.   
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In previous decades, there has been considerable success in the development of targeted 
therapies for diseases with single causal targets, such as Fabry's disease (Gahl). Additionally, 
there are many successful ways to treat some complex diseases such as hypertension and 
inflammatory diseases like arthritis. However, such treatments have been developed empirically 
and it is not entirely clear why certain drugs are effective in certain patients. Whereas originally 
medications were thought to hit a specific target and modulate effects through pathways 
downstream of that target, we now know that many drugs hit multiple targets, each of which 
exist within a complex network. The effects of the drug, in terms of both therapeutic actions and 
adverse events, are therefore a result of perturbation of the complex network landscape (Xie, Li 
and Bourne). Incorporating these predicted off-targets into a network of metabolic, signaling and 
gene regulatory pathways explained the different side-effect profiles of drugs in this class. 
Variations from person to person in the cellular networks due to external stimuli and genetic 
variation will likely affect the therapeutic response to medications, required dosing and 
susceptibility to adverse events and side effects. Furthermore, drugs can have both immediate 
acute effects as the drug initially interacts with its targets, and later effects as downstream 
signaling adjusts transcriptional regulation and leads to network rewiring resulting in delayed 
physiological action. 
Most of these effects are studied only with well-characterized molecules already known 
to have some kind of involvement in the process being studied. An alternative approach uses 
unbiased methods such as , expression profiling to study the effects of drugs.  These approaches 
are comprehensive and do not require any prior knowledge about the compound which is 
analyzed. Gene expression profiling data can then be processed to a “gene expression signature”; 
a subset of genes whose differential expression can be used as a marker of the activity of a given 
88 
 
pathway, disease or compound. Gene signatures can be used to discover “connections” among 
drugs, pathways, and diseases using a large collection of transcriptional responses following 
compound treatments, such as the “Connectivity Map” (J. Lamb; Lamb et al.). These compound-
specific expression profiles can be queried with a gene signature to recover a subset of 
compounds connected to the signature of interest. A compound is selected if genes in the 
signature are significantly modulated in the compound-specific transcriptional response. If a 
gene signature for a new compound is available, it is then possible to search the collection of 
transcriptional responses with that signature to identify well-characterized drugs, which behave 
similarly, and thus infer the mechanism of action of the new compound.  
The problems affecting gene signature-based methods are in the choice of the subset of 
genes composing the signature, and in the proper handling of multiple expression profiles 
obtained by treating different cell lines with the same compound. The wrong selection of genes 
in the signature will lead to the capture similarities in the experimental settings rather than in the 
drug mechanisms of action. Because of these limitations, the analysis of the transcriptional 
response to a new compound is usually performed by mapping the most differentially expressed 
genes, following compound treatment, onto known biological pathways in order to detect the 
most perturbed pathways. Such attempts are met with limited success due to the complexity of 
“backtracking” expression changes to primary causes (i.e., molecular targets).  
Inspired by these considerations, we developed a computational biology method to find 
master drivers (regulators) which cause genome-wide phenotypic variations. This is the inverse 
problem of predicting perturbation effects described in Chapter 4, in which identifying 
potentially direct targets of a perturbagen was the major goal. This approach covers all given 
(annotated) candidate regulators such as transcription factors and modulators. Because 
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differential expressions are predicted genome-wide, the side effects which highly coupled 
pathways might still miss can be considered. Thus, after predicting each gene’s asymptotic 
propagation effect of perturbation, we then compare the predicted differential expressions with 
the real ones using PWEA. If the predicted  responses to a perturbation are similar to real ones, 
the perturbed regulators are selected as candidate master drivers. This will allow the prediction 
of more appropriate anticancer therapeutic targets, and the discovery of previously unreported 





5.2 Materials and Methods 
Phenotypic variations observed between control and treated  groups are believed to 
result from genome-wide functional alterations as a consequence of the action of internal or 
external stimuli (perturbagens) on a cellular system. Assuming that a perturbagen directly affects 
the expression or activity of a single gene , its causal effects propagate throughout the cellular 
system, and the phenotype is revealed due to  direct and indirect effects of the perturbation. In 
this work we develop tools to predict the master drivers (regulators) which systematically cause 
this given phenotypic variations.  
As in Chapter 4, this Materials and Methods chapter is functionally separated into 
prediction procedures and performance testing procedures. Because Chapter 5 is conceptually the 
inverse problem of Chapter 4, prediction systems and the experimentally validated database are 
exactly the same as previously described. In Chapter 4, a known target was directly perturbed 
and we tried to predict the resulting genome-wide differential expression patterns, whereas in 
Chapter 5  we will develop methods  to predict master drivers  based on real experimental gene 
expression data. 
5.2.1 Prediction procedures 
The procedure for genome-wide prediction of each gene’s perturbation effect  is the same 
as in Chapter 4. However, each performance should be tested with different procedure unlike 
Chapter 4. Because the prediction performance in Chapter 4 was shown to be highly accurate, we 
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can predict genome-wide perturbation effects for each gene which is assumed to be the target of 
perturbagen and when a given amount of perturbation is applied to the gene.  
The more sophisticated the network biology we use, the better the predictive 
performance we have. Therefore, hARACNe was upgraded from ARACNe by applying higher 
order DPI (Han) and was validated with ChIP-chip and siRNA libraries such that this algorithm 
efficiently pruned indirect interactions in cascades of three or more nodes (Chapter 2). In 
addition, mode-of-modulator-action-free post-translational global modulators based on 
coMINDy algorithm (Chapter 3) were proposed and computationally validated to be more 
predictive than MINDy (Chapter 4). Thus, the combination of hARACNe and coMINDy might 
cover more sophisticated regulatory networks in mammalian cells, and this network topology is 
used to build the predictive regulatory unit (Markov blanket) in our predictive framework. 
We already showed that transcriptional networks inferred by hARACNe and post-
translational global modulators post-processed with coMINDy triplets were statistically 
strengthened and outperformed other combinations (Chapter 4). Thus, we simulated and 
predicted the master drivers using a combination of transcriptional and post-translational 
networks. Every gene applied by 1st order Markov Blanket (Judea  Pearl; Judea Pearl) has its 
regulatory blanket and ‘ubiquitous’ selection for reducing computational complexity was applied 
to all the interactions in given blankets (Materials and Methods in Chapter 4). Regulatory effects 
on a hub gene are probabilistically trained with other genes in the blanket using the proposed 
Bayesian model. 
Again, a Trellis-like diagram is helpful to understand how we design this inverse 
problem: how drastically complicated regulatory mechanisms are coupled, and how the 
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perturbation effects are systematically propagated within them. Iterative prediction steps show 
how causal effects of regulation are propagated and how these effects are updated in each step 
(See Figure 5-1).  
Figure 5-1. All candidates of master driver (either TF or M) are simulated in parallel with the 
same prediction framework designed in Chapter 4. 
 
Despite the fact that the additive model (AM) described in Chapter 4 might be applied, 
we already showed that the Bayesian model, where each node in a regulatory blanket is regarded 
as a random variable, is more advantageous when checking its predictive performance and 
computing cost. Thus, we used the Bayesian model as an efficient way to predict relative 
differential expression of all hub genes which are assumed to be individually perturbed by a 
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given amount in test profiles, based on combining among all repositories of partial conditional 
PDFs in order to approximately restore their full conditional distribution. 
Assuming that all potential regulators (for example the 2674 signaling genes and 848 
transcription factors in Table 3-2 are perturbed), a total of 3435 simulations have been run to 
predict relative differential expression levels. Because we showed the prediction of perturbation 
effects was highly accurate in Chapter 4, the master drivers which cause the given phenotypic 
variations should also be accurately  predicted. Thus, among the predicted 3435 differentially 
expressed genes, we need to design a general performance testing measure which is simple but 
not biased.  
5.2.2 Performance testing  
Similar to the performance testing in Chapter 4, in each perturbation case, the real 
effects of a perturbation are thought to arrive at a steady state after a certain time. Thus, the 
predicted effects of a perturbation should also arrive at steady states after a number of iterative 
steps. Unlike Chapter 4, the second performance testing using random networks was discarded 
from our consideration because all genes (regulators) were potential candidates of master driver 
and also because we already checked that predicted performance was not achieved randomly 
(Chapter 4). Thus, when the given amount of perturbation (differential expression of given gene 
which is assumed to be directly perturbed) is applied to given regulator, the causal effect of 
perturbation propagates in its own way in the reconstructed regulatory network.  
 Based on an iterative prediction framework, the activities of all genes at  any iteration 
step are predicted and updated by the proposed blanket-based Bayesian model. Expression levels 
of the previous iterative step and updated expression levels presumably propagate to the next 
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iterative step through the network. Because the model already showed impressive prediction 
performance with experimentally validated data, we concluded that the predictive system was 
properly designed to explain a real regulatory system in human cells. As a result, we observed 
that the results of prediction with the Bayesian model converge to some limited extent with their 
real regulatory scenarios. So, it is essential to check whether given simple convergence tests 
(referred to Chapter 4) were passed in each perturbation. Here we again set the σ∂  automatically 
within 10% of the standard deviation of the predicted expression of the gene in GEP. 
We followed the same methodology when setting up initial conditions in simulating 
controls and perturbation experiments. The initial condition for each gene, was set as its average 
expression levels across samples in the training data (GEPs) with the exception of the perturbed 
gene. The reason to set these initial conditions was to avoid abrupt changes in the dynamics of 
any given gene. In testing data, which was composed of control and treatment microarray 
samples manipulated by shRNA, average levels of the perturbed gene in control samples and 
treatment samples were initially applied to the prediction step and were fixed through all iterative 
steps. In cases when multiple probe IDs map to one Entrez ID, we applied the same procedure to 
all probe IDs   simultaneously. From the systematical viewpoint, both control and treatment 
conditions should be simultaneously predicted with the same initial conditions except those of 
the perturbed regulator; otherwise, it would suffer from prediction bias, which means that if 
prediction was simulated for treatment, then a predictive simulation for control should be applied. 
Like Chapter 4, differential expression was considered rather than absolute expression levels 




 As mentioned earlier, the parametric weighted enrichment analysis (PWEA) (Kim and 
Volsky; Alvarez)  was used to compute 3435 normalized enrichment scores to achieve more 
statistical power than gene-centric analysis which uses only the most significant portion of a list 
of all genes such as top 10 or 100, and consequently loses its statistical power to detect gene sets 
enriched in moderately affected genes. Thus, PWEA or GSEA might take the order of the longer 
list of genes (a.k.a. gene set) into account which leads to much less loss of information. 
However, there might be a drawback in PWEA or GSEA when computing the normalized 
enrichment score (NES). This is because resolution of a nominal p-value and NES in GSEA is 
highly affected by the reference list. Here, the reference statistics are formed using absolute 
values of predicted differential expression considering both up-regulated and down-regulated 
simultaneously. The gene set was statistically selected by applying a t-test with control and 
treatment samples in experimental perturbation data.  
We tested our predictive performance which was bias free and well characterized. The 
NES computed by PWEA in each perturbed regulator is a distinct measure of proximity to a real 
master driver. If parametric NES computation by PWEA is biased, then the NES of all other 
genes, computed by PWEA, have the same biases. Thus, the rank of NES values preserves their 
relativity. In addition, we consider the performance of predicting master regulators not using a 
single target but using a 1st order Markov blanket because  direct perturbation effects might be 
similarly produced by the perturbation of its 1st neighbors. Thus, final ranks were computed with 






A major challenge in drug target discovery is to distinguish the molecular targets of a 
bioactive compound from the hundreds to thousands of additional gene products that respond 
directly and indirectly to change in the activity of the perturbed target. Here, using a 
computationally validated prediction method, we present an integrated computational-
experimental approach for computing the likelihood that gene products and regulatory network 
based targets of a perturbagen. This is achieved by reverse-engineered model of the cell's gene 
regulatory network. We applied the prediction method to a set of human B cell expression 
profiles resulting from a variety of phenotypes (normal and tumor related mature human B cells). 
  
 












































































































Figure 5-2 The NES performance of known perturbed gene’s NES along the selected gene set. 
Black thick line is the NES value from real perturbed gene (predictive performance of real 
perturbed gene which results in the phenotypic variations between shRNA treated group samples 
and control samples). 
 
We simulated and demonstrated our master driver prediction performances with 
experimentally validated perturbation datasets where the perturbed master driver such as 
BHLHB2, MEF2B, FOXM1, MYB, STK38, and HDAC1 was known. Results were 
experimentally validated to be highly predictive as shown Figure 5-2 and 5-3. With 848 TFs 
2674 signaling proteins at the Entrez ID level, totally 3435 regulators were found to be 
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individually perturbed. In each supposed perturbed case, a selected gene was  perturbed by the 
average differential expression level between control and case group samples. By inputting these 
values, we could predict the relative differential expression caused by a given perturbation. In 
each case of predictive simulation, the corresponding NES was computed by PWEA; thus, 3435 
NESs were calculated in parallel after independently running the prediction framework 3435 
times. The effect of perturbation seems not only to be from the directly perturbed gene, but also 
to be from its first upstream or downstream neighbors. Thus, we considered the rank of NES not 
from individual NES values but from averaged NES in a given hub gene’s Markov blanket.  
Predictive quality was determined in chapter 4 by comparison of the PWEA pre-ranked 
test with the reference set which was ranked from the most down-regulated to the most up-
regulated gene following the in silico simulation, and selected gene set which was chosen in 
differentially expressed genes by having statistical significance level from the experimentally 
perturbed dataset. We used a variable threshold of significance to determine whether the 
enrichment would be consistent across a broad range of significance values, indicating that the 
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Figure 5-3 The predictive rank of real master driver which was perturbed by shRNA treatment. 
Y-axis means the rank among 3435 candidates and x-axis means the cutoff threshold to select 










While many drugs have known therapeutic targets, many drugs that are currently used 
work through unknown mechanisms. Furthermore, even drugs with a known target often have 
‘off-target’ effects. These are often undesirable effects of a drug which cannot be explained 
through its sub-networks (i.e. pathway) with its primary targets. For example, many drugs can 
cause cardiac arrhythmias by blocking potassium channels in the heart even though this was not 
the primary target or indication for these drugs (Hoffmann and Warner).  
Regulatory network approaches in systems biology have proven to be useful for 
organizing high-throughput biological datasets and extracting meaningful information. A 
regulatory network is a way of representing datasets emphasizing the relationships between 
genes. In recent years, studies of transcriptional regulatory networks and post-translational 
networks have provided insight into the origins of overall cellular behaviors as well as more 
focused fields of study concerning specific diseases. In a similar manner, analysis of networks 
for pharmacologic studies has the promise of allowing for the identification of new drug targets 
for many diseases, better understanding of what makes a good drug target, improved ability to 
predict effective drug combinations and drug adverse events. These studies contribute to shifting 
the paradigm of drug action from a relatively simple cascade of signaling events downstream of 
a target to a coordinated response to multiple perturbations of the cellular network. 
With an optimistic view of network biology in drug target discovery, several studies have 
investigated the network properties of drug targets. A bipartite network connecting drug targets 
and drugs was analyzed in the context of a global protein–protein interaction network (Ma'ayan 
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et al.). This work showed that drug targets are not randomly distributed throughout the cellular 
interaction network. Similarly, a bipartite network of drugs and targets was used to generate 
projections (Yildirim et al.). In one projection, nodes are drugs and are connected if they share a 
common target. In the other projection, nodes are the drug targets, the cellular components which 
interact with a drug. Overlaying this with a protein–protein interaction network allowed several 
observations of network properties of drug targets. Various measures of network centrality were 
used to calculate the topological importance of the drugs in the network and found that certain 
drugs, with multiple targets, are used to treat distinct diseases in different parts of the network. 
From these analyses, one can begin to formulate a set of network criteria that define a good drug 
target and allow for selection of new drug targets from the network.  
However, because too much disruption by a drug in a cellular network can lead to 
undesirable effects, a more pessimistic viewpoint of network biology approach should be 
considered. Potential drug targets may or may not be core regulators of important pathways: thus, 
when targeted, they might have major global effects and drug side effects or might not have 
those effects. To consider overall effects and adverse side effect altogether, given networks 
should be globally analyzed. The dominant type of analyses based on known pathways have 
blocked these global analyses in drug target discovery. Ideally, networks for specific diseases 
must be constructed to find targets globally in treatment of these diseases.  
Due to high-throughput technologies such as microarray and next generation sequencing, 
personalized genomic diagnosis is now possible and opens a new era to patients. However, since 
pathway-based analysis has been dominant, very limited genes have been identified as disease 
biomarkers and these data were partially interpreted. In addition, each measured dataset per 
patient was highly dependent on each patient and cumulative datasets from patients with the 
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same diagnosis were not clustered together; this means that their phenotypes seem to be 
different. This might generate different gene signatures or biomarkers from the same disease 
phenotype, thus it is very hard to find personal genomic treatment or druggable targets. As 
mentioned above,  pathway-based analysis suffers from the fact that it is hard to find consensus 
activities following pathway scenarios, knowing some specific effects of perturbagen is not 
enough to explain the activities of downstream targets...  Personalized master drivers (regulators) 
in the context of perturbations should be taken into consideration and when an identified master 
driver is experimentally perturbed, the perturbation effect should reflect the real genome-wide 
differentiation between persons or phenotypes. However, there is no genome-wide validated 
perturbation study; furthermore, the master driver identification method is still in its infancy and 
limited to transcriptional activities. In order to predict the effect of perturbation genome-wide, 
we already proposed Regulatory Network based prediction in Chapter 4. In addition, in silico 
prediction was done for master drivers which generate phenotypic variations. Because 
reconstructed regulatory networks are genome-wide they mimic well real cellular mechanisms 
Regulatory network-based prediction of phenotypic variation has enabled an explanation of 
which master driver presumably causes given genome-wide phenotypic variations. 
Because of the ‘inverse problem of the genome-wide effects of perturbation’ in 
computational methods, we computationally identified the cause of genome-wide phenotypic 
variation. As a result, we detected master drivers as the specific cause of given differential 
expressions in a human B cells. This research introduced several innovations; (1) instead of the 
previous pathway-dominant studies, we identified phenotype-specific master drivers in human B 
cells under the scenario of distinct perturbation prediction of all potential regulators; (2) rather 
than analyzing the causality of individual regulators, we grouped master regulators from their 
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Markov blanket. Biologically, this is quite plausible, since biochemical perturbations as well as a 
wide variety of external stimuli (temperature, pressure, etc) will similarly affect the cellular 
mechanisms directly upstream or downstream of the regulator; (3) we experimentally validated 
six distinct perturbation datasets (perturbagen phenotypes) of the BHLHB2, HDAC1, MEF2B, 
STK38, FOXM1 and MYB genes in B-cell lines. These genes all have roles as transcription 
factors or modulators or both in mixed regulatory networks. In each case, we identified most 
differentially expressed genes based on proposed fitting models; (4) finally, we tested our 
prediction performance with the rank of NESs computed by PWEA which provides the statistical 
power of predictive precision with gene sets which are statistically significant by t-tests. 
We simulated the propagation of 3435 genetic perturbations on integrated gene 
regulatory networks inferred by the hARACNe and coMINDy algorithms from human B cell 
data. hARACNe was experimentally validated by ChIP-chip or siRNA library and coMINDy 
was computationally validated by improvement of predictive performance. However, the 
activities of signaling proteins tend to be much less correlated and out of scope with mRNA 
expression. Thus, the overall performance of pleiotropic signaling proteins such as STK38 
tended to produce less robust and lower performance than that of transcription factors (BHLHB2, 
MEF2B, FOXM1, and MYB) or a specific regulatory protein (HDAC1).  However, there exist 
more attractive advantages of these approaches because they cover all potential regulators and 
the coverage is much larger than other approaches (Xing and Gardner; di Bernardo, Bansal and 
Della Gatta; di Bernardo et al. "Chemogenomic Profiling on a Genomewide Scale Using 
Reverse-Engineered Gene Networks"; Gardner et al.; Lauria, Iorio and di Bernardo). These 
approaches which only utilized transcriptional regulatory networks were incapable of identifying 
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Appendix Figure 1. Convergence: Bayesian model with 15 neighbors in each 1st order Markov 
blanket. This shows that the convergence in Bayesian model does not highly depend on how 




Appendix Figure 2. Divergence: Regression model with 15 neighbors in each 1st order Markov 




Appendix Figure 3. Examples: regression model shows slower convergence rate than that of 
Bayesian model. Generally, hundreds of iterations are needed in regression, whereas tens of 




Appendix Figure 4. Is convergence guaranteed? Examples: depending on model selection, the 




Appendix Figure 5. BHLHB2 with cutoff P-value = 0.01. Enrichment score comparison 






Appendix Figure 6. HDAC1 with cutoff P-value = 0.01. Enrichment score comparison between 






Appendix Figure 7. MEF2B with cutoff P-value = 0.01. Enrichment score comparison between 






Appendix Figure 8. STK38 with cutoff P-value = 0.01. Enrichment score comparison between 







Appendix Figure 9. FOXM1 with cutoff P-value = 0.01. Enrichment score comparison between 








Appendix Figure 10. MYB with cutoff P-value = 0.01. Enrichment score comparison between 





































































































































Appendix Equation 1 
 
